{"paper_id":"09b99f02-3b5d-4db8-9b4e-7b368b270429","body_text":"Therapeutic Use of Cannabis: Perceptions of Youth... | F1000Research <!-- --> <!-- --> <!-- This is commented out to fix display problems on mobile devices. We may use it again once we implement a responsive design that supports native device resolutions. --> \"use strict\";function _typeof(t){return(_typeof=\"function\"==typeof Symbol&&\"symbol\"==typeof Symbol.iterator?function(t){return typeof t}:function(t){return t&&\"function\"==typeof Symbol&&t.constructor===Symbol&&t!==Symbol.prototype?\"symbol\":typeof t})(t)}!function(){var t=function(){var t,e,o=[],n=window,r=n;for(;r;){try{if(r.frames.__tcfapiLocator){t=r;break}}catch(t){}if(r===n.top)break;r=r.parent}t||(!function t(){var e=n.document,o=!!n.frames.__tcfapiLocator;if(!o)if(e.body){var r=e.createElement(\"iframe\");r.style.cssText=\"display:none\",r.name=\"__tcfapiLocator\",e.body.appendChild(r)}else setTimeout(t,5);return!o}(),n.__tcfapi=function(){for(var t=arguments.length,n=new Array(t),r=0;r 3&&2===parseInt(n[1],10)&&\"boolean\"==typeof n[3]&&(e=n[3],\"function\"==typeof n[2]&&n[2](\"set\",!0)):\"ping\"===n[0]?\"function\"==typeof n[2]&&n[2]({gdprApplies:e,cmpLoaded:!1,cmpStatus:\"stub\"}):o.push(n)},n.addEventListener(\"message\",(function(t){var e=\"string\"==typeof t.data,o={};if(e)try{o=JSON.parse(t.data)}catch(t){}else o=t.data;var n=\"object\"===_typeof(o)&&null!==o?o.__tcfapiCall:null;n&&window.__tcfapi(n.command,n.version,(function(o,r){var a={__tcfapiReturn:{returnValue:o,success:r,callId:n.callId}};t&&t.source&&t.source.postMessage&&t.source.postMessage(e?JSON.stringify(a):a,\"*\")}),n.parameter)}),!1))};\"undefined\"!=typeof module?module.exports=t:t()}(); dataLayer = dataLayer || []; // Standard GTM initialization - Google Consent Mode handles consent automatically (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl+ '>m_auth=hzk0Vc3qFsQYhCrIoHz68A>m_preview=env-1>m_cookies_win=x';f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-MWFK8L5J'); ;window.NREUM||(NREUM={});NREUM.init={distributed_tracing:{enabled:true},privacy:{cookies_enabled:true},ajax:{deny_list:[\"bam.nr-data.net\"]}}; ;NREUM.loader_config={accountID:\"438030\",trustKey:\"438030\",agentID:\"772317073\",licenseKey:\"97f8f67f26\",applicationID:\"772317073\"} ;NREUM.info={beacon:\"bam.nr-data.net\",errorBeacon:\"bam.nr-data.net\",licenseKey:\"97f8f67f26\",applicationID:\"772317073\",sa:1} ;/*! For license information please see nr-loader-spa-1.236.0.min.js.LICENSE.txt */ (()=>{\"use strict\";var e,t,r={5763:(e,t,r)=>{r.d(t,{P_:()=>l,Mt:()=>g,C5:()=>s,DL:()=>v,OP:()=>T,lF:()=>D,Yu:()=>y,Dg:()=>h,CX:()=>c,GE:()=>b,sU:()=>_});var n=r(8632),i=r(9567);const o={beacon:n.ce.beacon,errorBeacon:n.ce.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0},a={};function s(e){if(!e)throw new Error(\"All info objects require an agent identifier!\");if(!a[e])throw new Error(\"Info for \".concat(e,\" was never set\"));return a[e]}function c(e,t){if(!e)throw new Error(\"All info objects require an agent identifier!\");a[e]=(0,i.D)(t,o),(0,n.Qy)(e,a[e],\"info\")}var u=r(7056);const d=()=>{const e={blockSelector:\"[data-nr-block]\",maskInputOptions:{password:!0}};return{allow_bfcache:!0,privacy:{cookies_enabled:!0},ajax:{deny_list:void 0,enabled:!0,harvestTimeSeconds:10},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},session:{domain:void 0,expiresMs:u.oD,inactiveMs:u.Hb},ssl:void 0,obfuscate:void 0,jserrors:{enabled:!0,harvestTimeSeconds:10},metrics:{enabled:!0},page_action:{enabled:!0,harvestTimeSeconds:30},page_view_event:{enabled:!0},page_view_timing:{enabled:!0,harvestTimeSeconds:30,long_task:!1},session_trace:{enabled:!0,harvestTimeSeconds:10},harvest:{tooManyRequestsDelay:60},session_replay:{enabled:!1,harvestTimeSeconds:60,sampleRate:.1,errorSampleRate:.1,maskTextSelector:\"*\",maskAllInputs:!0,get blockClass(){return\"nr-block\"},get ignoreClass(){return\"nr-ignore\"},get maskTextClass(){return\"nr-mask\"},get blockSelector(){return e.blockSelector},set blockSelector(t){e.blockSelector+=\",\".concat(t)},get maskInputOptions(){return e.maskInputOptions},set maskInputOptions(t){e.maskInputOptions={...t,password:!0}}},spa:{enabled:!0,harvestTimeSeconds:10}}},f={};function l(e){if(!e)throw new Error(\"All configuration objects require an agent identifier!\");if(!f[e])throw new Error(\"Configuration for \".concat(e,\" was never set\"));return f[e]}function h(e,t){if(!e)throw new Error(\"All configuration objects require an agent identifier!\");f[e]=(0,i.D)(t,d()),(0,n.Qy)(e,f[e],\"config\")}function g(e,t){if(!e)throw new Error(\"All configuration objects require an agent identifier!\");var r=l(e);if(r){for(var n=t.split(\".\"),i=0;i {r.d(t,{D:()=>i});var n=r(50);function i(e,t){try{if(!e||\"object\"!=typeof e)return(0,n.Z)(\"Setting a Configurable requires an object as input\");if(!t||\"object\"!=typeof t)return(0,n.Z)(\"Setting a Configurable requires a model to set its initial properties\");const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let a in o)if(void 0!==e[a])try{\"object\"==typeof e[a]&&\"object\"==typeof t[a]?r[a]=i(e[a],t[a]):r[a]=e[a]}catch(e){(0,n.Z)(\"An error occurred while setting a property of a Configurable\",e)}return r}catch(e){(0,n.Z)(\"An error occured while setting a Configurable\",e)}}},6818:(e,t,r)=>{r.d(t,{Re:()=>i,gF:()=>o,q4:()=>n});const n=\"1.236.0\",i=\"PROD\",o=\"CDN\"},385:(e,t,r)=>{r.d(t,{FN:()=>a,IF:()=>u,Nk:()=>f,Tt:()=>s,_A:()=>o,il:()=>n,pL:()=>c,v6:()=>i,w1:()=>d});const n=\"undefined\"!=typeof window&&!!window.document,i=\"undefined\"!=typeof WorkerGlobalScope&&(\"undefined\"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||\"undefined\"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),o=n?window:\"undefined\"!=typeof WorkerGlobalScope&&(\"undefined\"!=typeof self&&self instanceof WorkerGlobalScope&&self||\"undefined\"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a=\"\"+o?.location,s=/iPad|iPhone|iPod/.test(navigator.userAgent),c=s&&\"undefined\"==typeof SharedWorker,u=(()=>{const e=navigator.userAgent.match(/Firefox[/\\s](\\d+\\.\\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),d=Boolean(n&&window.document.documentMode),f=!!navigator.sendBeacon},1117:(e,t,r)=>{r.d(t,{w:()=>o});var n=r(50);const i={agentIdentifier:\"\",ee:void 0};class o{constructor(e){try{if(\"object\"!=typeof e)return(0,n.Z)(\"shared context requires an object as input\");this.sharedContext={},Object.assign(this.sharedContext,i),Object.entries(e).forEach((e=>{let[t,r]=e;Object.keys(i).includes(t)&&(this.sharedContext[t]=r)}))}catch(e){(0,n.Z)(\"An error occured while setting SharedContext\",e)}}}},8e3:(e,t,r)=>{r.d(t,{L:()=>d,R:()=>c});var n=r(2177),i=r(1284),o=r(4322),a=r(3325);const s={};function c(e,t){const r={staged:!1,priority:a.p[t]||0};u(e),s[e].get(t)||s[e].set(t,r)}function u(e){e&&(s[e]||(s[e]=new Map))}function d(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:\"\",t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:\"feature\";if(u(e),!e||!s[e].get(t))return a(t);s[e].get(t).staged=!0;const r=[...s[e]];function a(t){const r=e?n.ee.get(e):n.ee,a=o.X.handlers;if(r.backlog&&a){var s=r.backlog[t],c=a[t];if(c){for(var u=0;s&&u {let[t,r]=e;return r.staged}))&&(r.sort(((e,t)=>e[1].priority-t[1].priority)),r.forEach((e=>{let[t]=e;a(t)})))}function f(e,t){var r=e[1];(0,i.D)(t[r],(function(t,r){var n=e[0];if(r[0]===n){var i=r[1],o=e[3],a=e[2];i.apply(o,a)}}))}},2177:(e,t,r)=>{r.d(t,{c:()=>f,ee:()=>u});var n=r(8632),i=r(2210),o=r(1284),a=r(5763),s=\"nr@context\";let c=(0,n.fP)();var u;function d(){}function f(e){return(0,i.X)(e,s,l)}function l(){return new d}function h(){u.aborted=!0,u.backlog={}}c.ee?u=c.ee:(u=function e(t,r){var n={},c={},f={},g=!1;try{g=16===r.length&&(0,a.OP)(r).isolatedBacklog}catch(e){}var p={on:b,addEventListener:b,removeEventListener:y,emit:v,get:x,listeners:w,context:m,buffer:A,abort:h,aborted:!1,isBuffering:E,debugId:r,backlog:g?{}:t&&\"object\"==typeof t.backlog?t.backlog:{}};return p;function m(e){return e&&e instanceof d?e:e?(0,i.X)(e,s,l):l()}function v(e,r,n,i,o){if(!1!==o&&(o=!0),!u.aborted||i){t&&o&&t.emit(e,r,n);for(var a=m(n),s=w(e),d=s.length,f=0;f<d;f++)s[f].apply(a,r);var l=T()[c[e]];return l&&l.push([p,e,r,a]),a}}function b(e,t){n[e]=w(e).concat(t)}function y(e,t){var r=n[e];if(r)for(var i=0;i {r.d(t,{E:()=>n,p:()=>i});var n=r(2177).ee.get(\"handle\");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}},4322:(e,t,r)=>{r.d(t,{X:()=>o});var n=r(5546);o.on=a;var i=o.handlers={};function o(e,t,r,o){a(o||n.E,i,e,t,r)}function a(e,t,r,i,o){o||(o=\"feature\"),e||(e=n.E);var a=t[o]=t[o]||{};(a[r]=a[r]||[]).push([e,i])}},3239:(e,t,r)=>{r.d(t,{bP:()=>s,iz:()=>c,m$:()=>a});var n=r(385);let i=!1,o=!1;try{const e={get passive(){return i=!0,!1},get signal(){return o=!0,!1}};n._A.addEventListener(\"test\",null,e),n._A.removeEventListener(\"test\",null,e)}catch(e){}function a(e,t){return i||o?{capture:!!e,passive:i,signal:t}:!!e}function s(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;window.addEventListener(e,t,a(r,n))}function c(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;document.addEventListener(e,t,a(r,n))}},4402:(e,t,r)=>{r.d(t,{Ht:()=>u,M:()=>c,Rl:()=>a,ky:()=>s});var n=r(385);const i=\"xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx\";function o(e,t){return e?15&e[t]:16*Math.random()|0}function a(){const e=n._A?.crypto||n._A?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(31))),i.split(\"\").map((e=>\"x\"===e?o(t,++r).toString(16):\"y\"===e?(3&o()|8).toString(16):e)).join(\"\")}function s(e){const t=n._A?.crypto||n._A?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(31)));const a=[];for(var s=0;s {r.d(t,{Bq:()=>n,Hb:()=>o,oD:()=>i});const n=\"NRBA\",i=144e5,o=18e5},7894:(e,t,r)=>{function n(){return Math.round(performance.now())}r.d(t,{z:()=>n})},7243:(e,t,r)=>{r.d(t,{e:()=>o});var n=r(385),i={};function o(e){if(e in i)return i[e];if(0===(e||\"\").indexOf(\"data:\"))return{protocol:\"data\"};let t;var r=n._A?.location,o={};if(n.il)t=document.createElement(\"a\"),t.href=e;else try{t=new URL(e,r.href)}catch(e){return o}o.port=t.port;var a=t.href.split(\"://\");!o.port&&a[1]&&(o.port=a[1].split(\"/\")[0].split(\"@\").pop().split(\":\")[1]),o.port&&\"0\"!==o.port||(o.port=\"https\"===a[0]?\"443\":\"80\"),o.hostname=t.hostname||r.hostname,o.pathname=t.pathname,o.protocol=a[0],\"/\"!==o.pathname.charAt(0)&&(o.pathname=\"/\"+o.pathname);var s=!t.protocol||\":\"===t.protocol||t.protocol===r.protocol,c=t.hostname===r.hostname&&t.port===r.port;return o.sameOrigin=s&&(!t.hostname||c),\"/\"===o.pathname&&(i[e]=o),o}},50:(e,t,r)=>{function n(e,t){\"function\"==typeof console.warn&&(console.warn(\"New Relic: \".concat(e)),t&&console.warn(t))}r.d(t,{Z:()=>n})},2587:(e,t,r)=>{r.d(t,{N:()=>c,T:()=>u});var n=r(2177),i=r(5546),o=r(8e3),a=r(3325);const s={stn:[a.D.sessionTrace],err:[a.D.jserrors,a.D.metrics],ins:[a.D.pageAction],spa:[a.D.spa],sr:[a.D.sessionReplay,a.D.sessionTrace]};function c(e,t){const r=n.ee.get(t);e&&\"object\"==typeof e&&(Object.entries(e).forEach((e=>{let[t,n]=e;void 0===u[t]&&(s[t]?s[t].forEach((e=>{n?(0,i.p)(\"feat-\"+t,[],void 0,e,r):(0,i.p)(\"block-\"+t,[],void 0,e,r),(0,i.p)(\"rumresp-\"+t,[Boolean(n)],void 0,e,r)})):n&&(0,i.p)(\"feat-\"+t,[],void 0,void 0,r),u[t]=Boolean(n))})),Object.keys(s).forEach((e=>{void 0===u[e]&&(s[e]?.forEach((t=>(0,i.p)(\"rumresp-\"+e,[!1],void 0,t,r))),u[e]=!1)})),(0,o.L)(t,a.D.pageViewEvent))}const u={}},2210:(e,t,r)=>{r.d(t,{X:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},1284:(e,t,r)=>{r.d(t,{D:()=>n});const n=(e,t)=>Object.entries(e||{}).map((e=>{let[r,n]=e;return t(r,n)}))},4351:(e,t,r)=>{r.d(t,{P:()=>o});var n=r(2177);const i=()=>{const e=new WeakSet;return(t,r)=>{if(\"object\"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())}catch(e){try{n.ee.emit(\"internal-error\",[e])}catch(e){}}}},3960:(e,t,r)=>{r.d(t,{K:()=>a,b:()=>o});var n=r(3239);function i(){return\"undefined\"==typeof document||\"complete\"===document.readyState}function o(e,t){if(i())return e();(0,n.bP)(\"load\",e,t)}function a(e){if(i())return e();(0,n.iz)(\"DOMContentLoaded\",e)}},8632:(e,t,r)=>{r.d(t,{EZ:()=>u,Qy:()=>c,ce:()=>o,fP:()=>a,gG:()=>d,mF:()=>s});var n=r(7894),i=r(385);const o={beacon:\"bam.nr-data.net\",errorBeacon:\"bam.nr-data.net\"};function a(){return i._A.NREUM||(i._A.NREUM={}),void 0===i._A.newrelic&&(i._A.newrelic=i._A.NREUM),i._A.NREUM}function s(){let e=a();return e.o||(e.o={ST:i._A.setTimeout,SI:i._A.setImmediate,CT:i._A.clearTimeout,XHR:i._A.XMLHttpRequest,REQ:i._A.Request,EV:i._A.Event,PR:i._A.Promise,MO:i._A.MutationObserver,FETCH:i._A.fetch}),e}function c(e,t,r){let i=a();const o=i.initializedAgents||{},s=o[e]||{};return Object.keys(s).length||(s.initializedAt={ms:(0,n.z)(),date:new Date}),i.initializedAgents={...o,[e]:{...s,[r]:t}},i}function u(e,t){a()[e]=t}function d(){return function(){let e=a();const t=e.info||{};e.info={beacon:o.beacon,errorBeacon:o.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),s(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},7956:(e,t,r)=>{r.d(t,{N:()=>i});var n=r(3239);function i(e){let t=arguments.length>1&&void 0!==arguments[1]&&arguments[1],r=arguments.length>2?arguments[2]:void 0,i=arguments.length>3?arguments[3]:void 0;return void(0,n.iz)(\"visibilitychange\",(function(){if(t)return void(\"hidden\"==document.visibilityState&&e());e(document.visibilityState)}),r,i)}},1214:(e,t,r)=>{r.d(t,{em:()=>v,u5:()=>N,QU:()=>S,_L:()=>I,Gm:()=>L,Lg:()=>M,gy:()=>U,BV:()=>Q,Kf:()=>ee});var n=r(2177);const i=\"nr@original\";var o=Object.prototype.hasOwnProperty,a=!1;function s(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n=\"\");var a,s,c,u=\"-\"===n.charAt(0);for(c=0;c 2?n-2:0),o=2;o {r(A[T],e,w),r(E[T],e,w)})),r(l._A,\"fetch\",y),t.on(y+\"end\",(function(e,r){var n=this;if(r){var i=r.headers.get(\"content-length\");null!==i&&(n.rxSize=i),t.emit(y+\"done\",[null,r],n)}else t.emit(y+\"done\",[e],n)})),t}const O={},j=[\"pushState\",\"replaceState\"];function S(e){const t=function(e){return(e||n.ee).get(\"history\")}(e);return!l.il||O[t.debugId]++||(O[t.debugId]=1,s(t).inPlace(window.history,j,\"-\")),t}var P=r(3239);const C={},R=[\"appendChild\",\"insertBefore\",\"replaceChild\"];function I(e){const t=function(e){return(e||n.ee).get(\"jsonp\")}(e);if(!l.il||C[t.debugId])return t;C[t.debugId]=!0;var r=s(t),i=/[?&](?:callback|cb)=([^&#]+)/,o=/(.*)\\.([^.]+)/,a=/^(\\w+)(\\.|$)(.*)$/;function c(e,t){var r=e.match(a),n=r[1],i=r[3];return i?c(i,t[n]):t[n]}return r.inPlace(Node.prototype,R,\"dom-\"),t.on(\"dom-start\",(function(e){!function(e){if(!e||\"string\"!=typeof e.nodeName||\"script\"!==e.nodeName.toLowerCase())return;if(\"function\"!=typeof e.addEventListener)return;var n=(a=e.src,s=a.match(i),s?s[1]:null);var a,s;if(!n)return;var u=function(e){var t=e.match(o);if(t&&t.length>=3)return{key:t[2],parent:c(t[1],window)};return{key:e,parent:window}}(n);if(\"function\"!=typeof u.parent[u.key])return;var d={};function f(){t.emit(\"jsonp-end\",[],d),e.removeEventListener(\"load\",f,(0,P.m$)(!1)),e.removeEventListener(\"error\",l,(0,P.m$)(!1))}function l(){t.emit(\"jsonp-error\",[],d),t.emit(\"jsonp-end\",[],d),e.removeEventListener(\"load\",f,(0,P.m$)(!1)),e.removeEventListener(\"error\",l,(0,P.m$)(!1))}r.inPlace(u.parent,[u.key],\"cb-\",d),e.addEventListener(\"load\",f,(0,P.m$)(!1)),e.addEventListener(\"error\",l,(0,P.m$)(!1)),t.emit(\"new-jsonp\",[e.src],d)}(e[0])})),t}var k=r(5763);const H={};function L(e){const t=function(e){return(e||n.ee).get(\"mutation\")}(e);if(!l.il||H[t.debugId])return t;H[t.debugId]=!0;var r=s(t),i=k.Yu.MO;return i&&(window.MutationObserver=function(e){return this instanceof i?new i(r(e,\"fn-\")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype),t}const z={};function M(e){const t=function(e){return(e||n.ee).get(\"promise\")}(e);if(z[t.debugId])return t;z[t.debugId]=!0;var r=n.c,o=s(t),a=k.Yu.PR;return a&&function(){function e(r){var n=t.context(),i=o(r,\"executor-\",n,null,!1);const s=Reflect.construct(a,[i],e);return t.context(s).getCtx=function(){return n},s}l._A.Promise=e,Object.defineProperty(e,\"name\",{value:\"Promise\"}),e.toString=function(){return a.toString()},Object.setPrototypeOf(e,a),[\"all\",\"race\"].forEach((function(r){const n=a[r];e[r]=function(e){let i=!1;[...e||[]].forEach((e=>{this.resolve(e).then(a(\"all\"===r),a(!1))}));const o=n.apply(this,arguments);return o;function a(e){return function(){t.emit(\"propagate\",[null,!i],o,!1,!1),i=i||!e}}}})),[\"resolve\",\"reject\"].forEach((function(r){const n=a[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit(\"propagate\",[e,!0],r,!1,!1),r}})),e.prototype=a.prototype;const n=a.prototype.then;a.prototype.then=function(){var e=this,i=r(e);i.promise=e;for(var a=arguments.length,s=new Array(a),c=0;c e())),t};function m(e,t){i.inPlace(t,[\"onreadystatechange\"],\"fn-\",E)}function b(){var e=this,t=r.context(e);e.readyState>3&&!t.resolved&&(t.resolved=!0,r.emit(\"xhr-resolved\",[],e)),i.inPlace(e,f,\"fn-\",E)}if(function(e,t){for(var r in e)t[r]=e[r]}(o,p),p.prototype=o.prototype,i.inPlace(p.prototype,J,\"-xhr-\",E),r.on(\"send-xhr-start\",(function(e,t){m(e,t),function(e){h.push(e),a&&(y?y.then(A):u?u(A):(w=-w,x.data=w))}(t)})),r.on(\"open-xhr-start\",m),a){var y=c&&c.resolve();if(!u&&!c){var w=1,x=document.createTextNode(w);new a(A).observe(x,{characterData:!0})}}else t.on(\"fn-end\",(function(e){e[0]&&e[0].type===d||A()}));function A(){for(var e=0;e {r.d(t,{t:()=>n});const n=r(3325).D.ajax},6660:(e,t,r)=>{r.d(t,{A:()=>i,t:()=>n});const n=r(3325).D.jserrors,i=\"nr@seenError\"},3081:(e,t,r)=>{r.d(t,{gF:()=>o,mY:()=>i,t9:()=>n,vz:()=>s,xS:()=>a});const n=r(3325).D.metrics,i=\"sm\",o=\"cm\",a=\"storeSupportabilityMetrics\",s=\"storeEventMetrics\"},4649:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageAction},7633:(e,t,r)=>{r.d(t,{Dz:()=>i,OJ:()=>a,qw:()=>o,t9:()=>n});const n=r(3325).D.pageViewEvent,i=\"firstbyte\",o=\"domcontent\",a=\"windowload\"},9251:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageViewTiming},3614:(e,t,r)=>{r.d(t,{BST_RESOURCE:()=>i,END:()=>s,FEATURE_NAME:()=>n,FN_END:()=>u,FN_START:()=>c,PUSH_STATE:()=>d,RESOURCE:()=>o,START:()=>a});const n=r(3325).D.sessionTrace,i=\"bstResource\",o=\"resource\",a=\"-start\",s=\"-end\",c=\"fn\"+a,u=\"fn\"+s,d=\"pushState\"},7836:(e,t,r)=>{r.d(t,{BODY:()=>A,CB_END:()=>E,CB_START:()=>u,END:()=>x,FEATURE_NAME:()=>i,FETCH:()=>_,FETCH_BODY:()=>v,FETCH_DONE:()=>m,FETCH_START:()=>p,FN_END:()=>c,FN_START:()=>s,INTERACTION:()=>l,INTERACTION_API:()=>d,INTERACTION_EVENTS:()=>o,JSONP_END:()=>b,JSONP_NODE:()=>g,JS_TIME:()=>T,MAX_TIMER_BUDGET:()=>a,REMAINING:()=>f,SPA_NODE:()=>h,START:()=>w,originalSetTimeout:()=>y});var n=r(5763);const i=r(3325).D.spa,o=[\"click\",\"submit\",\"keypress\",\"keydown\",\"keyup\",\"change\"],a=999,s=\"fn-start\",c=\"fn-end\",u=\"cb-start\",d=\"api-ixn-\",f=\"remaining\",l=\"interaction\",h=\"spaNode\",g=\"jsonpNode\",p=\"fetch-start\",m=\"fetch-done\",v=\"fetch-body-\",b=\"jsonp-end\",y=n.Yu.ST,w=\"-start\",x=\"-end\",A=\"-body\",E=\"cb\"+x,T=\"jsTime\",_=\"fetch\"},5938:(e,t,r)=>{r.d(t,{W:()=>o});var n=r(5763),i=r(2177);class o{constructor(e,t,r){this.agentIdentifier=e,this.aggregator=t,this.ee=i.ee.get(e,(0,n.OP)(this.agentIdentifier).isolatedBacklog),this.featureName=r,this.blocked=!1}}},9144:(e,t,r)=>{r.d(t,{j:()=>m});var n=r(3325),i=r(5763),o=r(5546),a=r(2177),s=r(7894),c=r(8e3),u=r(3960),d=r(385),f=r(50),l=r(3081),h=r(8632);function g(){const e=(0,h.gG)();[\"setErrorHandler\",\"finished\",\"addToTrace\",\"inlineHit\",\"addRelease\",\"addPageAction\",\"setCurrentRouteName\",\"setPageViewName\",\"setCustomAttribute\",\"interaction\",\"noticeError\",\"setUserId\"].forEach((t=>{e[t]=function(){for(var r=arguments.length,n=new Array(r),i=0;i 1?r-1:0),i=1;i {e.exposed&&e.api[t]&&o.push(e.api[t](...n))})),o.length>1?o:o[0]}(t,...n)}}))}var p=r(2587);function m(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{},m=arguments.length>2?arguments[2]:void 0,v=arguments.length>3?arguments[3]:void 0,{init:b,info:y,loader_config:w,runtime:x={loaderType:m},exposed:A=!0}=t;const E=(0,h.gG)();y||(b=E.init,y=E.info,w=E.loader_config),(0,i.Dg)(e,b||{}),(0,i.GE)(e,w||{}),(0,i.sU)(e,x),y.jsAttributes??={},d.v6&&(y.jsAttributes.isWorker=!0),(0,i.CX)(e,y),g();const T=function(e,t){t||(0,c.R)(e,\"api\");const h={};var g=a.ee.get(e),p=g.get(\"tracer\"),m=\"api-\",v=m+\"ixn-\";function b(t,r,n,o){const a=(0,i.C5)(e);return null===r?delete a.jsAttributes[t]:(0,i.CX)(e,{...a,jsAttributes:{...a.jsAttributes,[t]:r}}),x(m,n,!0,o||null===r?\"session\":void 0)(t,r)}function y(){}[\"setErrorHandler\",\"finished\",\"addToTrace\",\"inlineHit\",\"addRelease\"].forEach((e=>h[e]=x(m,e,!0,\"api\"))),h.addPageAction=x(m,\"addPageAction\",!0,n.D.pageAction),h.setCurrentRouteName=x(m,\"routeName\",!0,n.D.spa),h.setPageViewName=function(t,r){if(\"string\"==typeof t)return\"/\"!==t.charAt(0)&&(t=\"/\"+t),(0,i.OP)(e).customTransaction=(r||\"http://custom.transaction\")+t,x(m,\"setPageViewName\",!0)()},h.setCustomAttribute=function(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2];if(\"string\"==typeof e){if([\"string\",\"number\"].includes(typeof t)||null===t)return b(e,t,\"setCustomAttribute\",r);(0,f.Z)(\"Failed to execute setCustomAttribute.\\nNon-null value must be a string or number type, but a type of was provided.\"))}else(0,f.Z)(\"Failed to execute setCustomAttribute.\\nName must be a string type, but a type of was provided.\"))},h.setUserId=function(e){if(\"string\"==typeof e||null===e)return b(\"enduser.id\",e,\"setUserId\",!0);(0,f.Z)(\"Failed to execute setUserId.\\nNon-null value must be a string type, but a type of was provided.\"))},h.interaction=function(){return(new y).get()};var w=y.prototype={createTracer:function(e,t){var r={},i=this,a=\"function\"==typeof t;return(0,o.p)(v+\"tracer\",[(0,s.z)(),e,r],i,n.D.spa,g),function(){if(p.emit((a?\"\":\"no-\")+\"fn-start\",[(0,s.z)(),i,a],r),a)try{return t.apply(this,arguments)}catch(e){throw p.emit(\"fn-err\",[arguments,this,\"string\"==typeof e?new Error(e):e],r),e}finally{p.emit(\"fn-end\",[(0,s.z)()],r)}}}};function x(e,t,r,i){return function(){return(0,o.p)(l.xS,[\"API/\"+t+\"/called\"],void 0,n.D.metrics,g),i&&(0,o.p)(e+t,[(0,s.z)(),...arguments],r?null:this,i,g),r?void 0:this}}function A(){r.e(439).then(r.bind(r,7438)).then((t=>{let{setAPI:r}=t;r(e),(0,c.L)(e,\"api\")})).catch((()=>(0,f.Z)(\"Downloading runtime APIs failed...\")))}return[\"actionText\",\"setName\",\"setAttribute\",\"save\",\"ignore\",\"onEnd\",\"getContext\",\"end\",\"get\"].forEach((e=>{w[e]=x(v,e,void 0,n.D.spa)})),h.noticeError=function(e,t){\"string\"==typeof e&&(e=new Error(e)),(0,o.p)(l.xS,[\"API/noticeError/called\"],void 0,n.D.metrics,g),(0,o.p)(\"err\",[e,(0,s.z)(),!1,t],void 0,n.D.jserrors,g)},d.il?(0,u.b)((()=>A()),!0):A(),h}(e,v);return(0,h.Qy)(e,T,\"api\"),(0,h.Qy)(e,A,\"exposed\"),(0,h.EZ)(\"activatedFeatures\",p.T),T}},3325:(e,t,r)=>{r.d(t,{D:()=>n,p:()=>i});const n={ajax:\"ajax\",jserrors:\"jserrors\",metrics:\"metrics\",pageAction:\"page_action\",pageViewEvent:\"page_view_event\",pageViewTiming:\"page_view_timing\",sessionReplay:\"session_replay\",sessionTrace:\"session_trace\",spa:\"spa\"},i={[n.pageViewEvent]:1,[n.pageViewTiming]:2,[n.metrics]:3,[n.jserrors]:4,[n.ajax]:5,[n.sessionTrace]:6,[n.pageAction]:7,[n.spa]:8,[n.sessionReplay]:9}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce(((t,r)=>(i.f[r](e,t),t)),[])),i.u=e=>(({78:\"page_action-aggregate\",147:\"metrics-aggregate\",242:\"session-manager\",317:\"jserrors-aggregate\",348:\"page_view_timing-aggregate\",412:\"lazy-feature-loader\",439:\"async-api\",538:\"recorder\",590:\"session_replay-aggregate\",675:\"compressor\",733:\"session_trace-aggregate\",786:\"page_view_event-aggregate\",873:\"spa-aggregate\",898:\"ajax-aggregate\"}[e]||e)+\".\"+{78:\"ac76d497\",147:\"3dc53903\",148:\"1a20d5fe\",242:\"2a64278a\",317:\"49e41428\",348:\"bd6de33a\",412:\"2f55ce66\",439:\"30bd804e\",538:\"1b18459f\",590:\"cf0efb30\",675:\"ae9f91a8\",733:\"83105561\",786:\"06482edd\",860:\"03a8b7a5\",873:\"e6b09d52\",898:\"998ef92b\"}[e]+\"-1.236.0.min.js\"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t=\"NRBA:\",i.l=(r,n,o,a)=>{if(e[r])e[r].push(n);else{var s,c;if(void 0!==o)for(var u=document.getElementsByTagName(\"script\"),d=0;d {s.onerror=s.onload=null,clearTimeout(h);var i=e[r];if(delete e[r],s.parentNode&&s.parentNode.removeChild(s),i&&i.forEach((e=>e(n))),t)return t(n)},h=setTimeout(l.bind(null,void 0,{type:\"timeout\",target:s}),12e4);s.onerror=l.bind(null,s.onerror),s.onload=l.bind(null,s.onload),c&&document.head.appendChild(s)}},i.r=e=>{\"undefined\"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:\"Module\"}),Object.defineProperty(e,\"__esModule\",{value:!0})},i.j=364,i.p=\"https://js-agent.newrelic.com/\",(()=>{var e={364:0,953:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise(((r,i)=>n=e[t]=[r,i]));r.push(n[2]=o);var a=i.p+i.u(t),s=new Error;i.l(a,(r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&(\"load\"===r.type?\"missing\":r.type),a=r&&r.target&&r.target.src;s.message=\"Loading chunk \"+t+\" failed.\\n(\"+o+\": \"+a+\")\",s.name=\"ChunkLoadError\",s.type=o,s.request=a,n[1](s)}}),\"chunk-\"+t,t)}};var t=(t,r)=>{var n,o,[a,s,c]=r,u=0;if(a.some((t=>0!==e[t]))){for(n in s)i.o(s,n)&&(i.m[n]=s[n]);if(c)c(i)}for(t&&t(r);u {i.r(o);var e=i(3325),t=i(5763);const r=Object.values(e.D);function n(e){const n={};return r.forEach((r=>{n[r]=function(e,r){return!1!==(0,t.Mt)(r,\"\".concat(e,\".enabled\"))}(r,e)})),n}var a=i(9144);var s=i(5546),c=i(385),u=i(8e3),d=i(5938),f=i(3960),l=i(50);class h extends d.W{constructor(e,t,r){let n=!(arguments.length>3&&void 0!==arguments[3])||arguments[3];super(e,t,r),this.auto=n,this.abortHandler,this.featAggregate,this.onAggregateImported,n&&(0,u.R)(e,r)}importAggregator(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{};if(this.featAggregate||!this.auto)return;const r=c.il&&!0===(0,t.Mt)(this.agentIdentifier,\"privacy.cookies_enabled\");let n;this.onAggregateImported=new Promise((e=>{n=e}));const o=async()=>{let t;try{if(r){const{setupAgentSession:e}=await Promise.all([i.e(860),i.e(242)]).then(i.bind(i,3228));t=e(this.agentIdentifier)}}catch(e){(0,l.Z)(\"A problem occurred when starting up session manager. This page will not start or extend any session.\",e)}try{if(!this.shouldImportAgg(this.featureName,t))return void(0,u.L)(this.agentIdentifier,this.featureName);const{lazyFeatureLoader:r}=await i.e(412).then(i.bind(i,8582)),{Aggregate:o}=await r(this.featureName,\"aggregate\");this.featAggregate=new o(this.agentIdentifier,this.aggregator,e),n(!0)}catch(e){(0,l.Z)(\"Downloading and initializing \".concat(this.featureName,\" failed...\"),e),this.abortHandler?.(),n(!1)}};c.il?(0,f.b)((()=>o()),!0):o()}shouldImportAgg(r,n){return r!==e.D.sessionReplay||!1!==(0,t.Mt)(this.agentIdentifier,\"session_trace.enabled\")&&(!!n?.isNew||!!n?.state.sessionReplay)}}var g=i(7633),p=i(7894);class m extends h{static featureName=g.t9;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];if(super(r,n,g.t9,i),(\"undefined\"==typeof PerformanceNavigationTiming||c.Tt)&&\"undefined\"!=typeof PerformanceTiming){const n=(0,t.OP)(r);n[g.Dz]=Math.max(Date.now()-n.offset,0),(0,f.K)((()=>n[g.qw]=Math.max((0,p.z)()-n[g.Dz],0))),(0,f.b)((()=>{const t=(0,p.z)();n[g.OJ]=Math.max(t-n[g.Dz],0),(0,s.p)(\"timing\",[\"load\",t],void 0,e.D.pageViewTiming,this.ee)}))}this.importAggregator()}}var v=i(1117),b=i(1284);class y extends v.w{constructor(e){super(e),this.aggregatedData={}}store(e,t,r,n,i){var o=this.getBucket(e,t,r,i);return o.metrics=function(e,t){t||(t={count:0});return t.count+=1,(0,b.D)(e,(function(e,r){t[e]=w(r,t[e])})),t}(n,o.metrics),o}merge(e,t,r,n,i){var o=this.getBucket(e,t,n,i);if(o.metrics){var a=o.metrics;a.count+=r.count,(0,b.D)(r,(function(e,t){if(\"count\"!==e){var n=a[e],i=r[e];i&&!i.c?a[e]=w(i.t,n):a[e]=function(e,t){if(!t)return e;t.c||(t=x(t.t));return t.min=Math.min(e.min,t.min),t.max=Math.max(e.max,t.max),t.t+=e.t,t.sos+=e.sos,t.c+=e.c,t}(i,a[e])}}))}else o.metrics=r}storeMetric(e,t,r,n){var i=this.getBucket(e,t,r);return i.stats=w(n,i.stats),i}getBucket(e,t,r,n){this.aggregatedData[e]||(this.aggregatedData[e]={});var i=this.aggregatedData[e][t];return i||(i=this.aggregatedData[e][t]={params:r||{}},n&&(i.custom=n)),i}get(e,t){return t?this.aggregatedData[e]&&this.aggregatedData[e][t]:this.aggregatedData[e]}take(e){for(var t={},r=\"\",n=!1,i=0;i t.max&&(t.max=e),e 2&&void 0!==arguments[2])||arguments[2];super(e,r,j.t,n),c.il&&((0,t.OP)(e).initHidden=Boolean(\"hidden\"===document.visibilityState),(0,N.N)((()=>(0,s.p)(\"docHidden\",[(0,p.z)()],void 0,j.t,this.ee)),!0),(0,O.bP)(\"pagehide\",(()=>(0,s.p)(\"winPagehide\",[(0,p.z)()],void 0,j.t,this.ee))),this.importAggregator())}}var P=i(3081);class C extends h{static featureName=P.t9;constructor(e,t){let r=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(e,t,P.t9,r),this.importAggregator()}}var R,I=i(2210),k=i(1214),H=i(2177),L={};try{R=localStorage.getItem(\"__nr_flags\").split(\",\"),console&&\"function\"==typeof console.log&&(L.console=!0,-1!==R.indexOf(\"dev\")&&(L.dev=!0),-1!==R.indexOf(\"nr_dev\")&&(L.nrDev=!0))}catch(e){}function z(e){try{L.console&&z(e)}catch(e){}}L.nrDev&&H.ee.on(\"internal-error\",(function(e){z(e.stack)})),L.dev&&H.ee.on(\"fn-err\",(function(e,t,r){z(r.stack)})),L.dev&&(z(\"NR AGENT IN DEVELOPMENT MODE\"),z(\"flags: \"+(0,b.D)(L,(function(e,t){return e})).join(\", \")));var M=i(6660);class B extends h{static featureName=M.t;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(r,n,M.t,i),this.skipNext=0;try{this.removeOnAbort=new AbortController}catch(e){}const o=this;o.ee.on(\"fn-start\",(function(e,t,r){o.abortHandler&&(o.skipNext+=1)})),o.ee.on(\"fn-err\",(function(t,r,n){o.abortHandler&&!n[M.A]&&((0,I.X)(n,M.A,(function(){return!0})),this.thrown=!0,(0,s.p)(\"err\",[n,(0,p.z)()],void 0,e.D.jserrors,o.ee))})),o.ee.on(\"fn-end\",(function(){o.abortHandler&&!this.thrown&&o.skipNext>0&&(o.skipNext-=1)})),o.ee.on(\"internal-error\",(function(t){(0,s.p)(\"ierr\",[t,(0,p.z)(),!0],void 0,e.D.jserrors,o.ee)})),this.origOnerror=c._A.onerror,c._A.onerror=this.onerrorHandler.bind(this),c._A.addEventListener(\"unhandledrejection\",(t=>{const r=function(e){let t=\"Unhandled Promise Rejection: \";if(e instanceof Error)try{return e.message=t+e.message,e}catch(t){return e}if(void 0===e)return new Error(t);try{return new Error(t+(0,D.P)(e))}catch(e){return new Error(t)}}(t.reason);(0,s.p)(\"err\",[r,(0,p.z)(),!1,{unhandledPromiseRejection:1}],void 0,e.D.jserrors,this.ee)}),(0,O.m$)(!1,this.removeOnAbort?.signal)),(0,k.gy)(this.ee),(0,k.BV)(this.ee),(0,k.em)(this.ee),(0,t.OP)(r).xhrWrappable&&(0,k.Kf)(this.ee),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}onerrorHandler(t,r,n,i,o){\"function\"==typeof this.origOnerror&&this.origOnerror(...arguments);try{this.skipNext?this.skipNext-=1:(0,s.p)(\"err\",[o||new F(t,r,n),(0,p.z)()],void 0,e.D.jserrors,this.ee)}catch(t){try{(0,s.p)(\"ierr\",[t,(0,p.z)(),!0],void 0,e.D.jserrors,this.ee)}catch(e){}}return!1}}function F(e,t,r){this.message=e||\"Uncaught error with no additional information\",this.sourceURL=t,this.line=r}let U=1;const q=\"nr@id\";function G(e){const t=typeof e;return!e||\"object\"!==t&&\"function\"!==t?-1:e===c._A?0:(0,I.X)(e,q,(function(){return U++}))}function V(e){if(\"string\"==typeof e&&e.length)return e.length;if(\"object\"==typeof e){if(\"undefined\"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if(\"undefined\"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!(\"undefined\"!=typeof FormData&&e instanceof FormData))try{return(0,D.P)(e).length}catch(e){return}}}var X=i(7243);class W{constructor(e){this.agentIdentifier=e,this.generateTracePayload=this.generateTracePayload.bind(this),this.shouldGenerateTrace=this.shouldGenerateTrace.bind(this)}generateTracePayload(e){if(!this.shouldGenerateTrace(e))return null;var r=(0,t.DL)(this.agentIdentifier);if(!r)return null;var n=(r.accountID||\"\").toString()||null,i=(r.agentID||\"\").toString()||null,o=(r.trustKey||\"\").toString()||null;if(!n||!i)return null;var a=(0,_.M)(),s=(0,_.Ht)(),c=Date.now(),u={spanId:a,traceId:s,timestamp:c};return(e.sameOrigin||this.isAllowedOrigin(e)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(a,s),u.traceContextStateHeader=this.generateTraceContextStateHeader(a,c,n,i,o)),(e.sameOrigin&&!this.excludeNewrelicHeader()||!e.sameOrigin&&this.isAllowedOrigin(e)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(a,s,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return\"00-\"+t+\"-\"+e+\"-01\"}generateTraceContextStateHeader(e,t,r,n,i){return i+\"@nr=0-1-\"+r+\"-\"+n+\"-\"+e+\"----\"+t}generateTraceHeader(e,t,r,n,i,o){if(!(\"function\"==typeof c._A?.btoa))return null;var a={v:[0,1],d:{ty:\"Browser\",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(a.d.tk=o),btoa((0,D.P)(a))}shouldGenerateTrace(e){return this.isDtEnabled()&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var r=!1,n={};if((0,t.Mt)(this.agentIdentifier,\"distributed_tracing\")&&(n=(0,t.P_)(this.agentIdentifier).distributed_tracing),e.sameOrigin)r=!0;else if(n.allowed_origins instanceof Array)for(var i=0;i 2&&void 0!==arguments[2])||arguments[2];super(r,n,Z.t,i),(0,t.OP)(r).xhrWrappable&&(this.dt=new W(r),this.handler=(e,t,r,n)=>(0,s.p)(e,t,r,n,this.ee),(0,k.u5)(this.ee),(0,k.Kf)(this.ee),function(r,n,i,o){function a(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},e.addEventListener(\"load\",(function(r){_(t,e)}),(0,O.m$)(!1)),c.IF||e.addEventListener(\"progress\",(function(e){t.lastSize=e.loaded}),(0,O.m$)(!1))}function s(e){this.params={method:e[0]},T(this,e[1]),this.metrics={}}function u(e,n){var i=(0,t.DL)(r);i.xpid&&this.sameOrigin&&n.setRequestHeader(\"X-NewRelic-ID\",i.xpid);var a=o.generateTracePayload(this.parsedOrigin);if(a){var s=!1;a.newrelicHeader&&(n.setRequestHeader(\"newrelic\",a.newrelicHeader),s=!0),a.traceContextParentHeader&&(n.setRequestHeader(\"traceparent\",a.traceContextParentHeader),a.traceContextStateHeader&&n.setRequestHeader(\"tracestate\",a.traceContextStateHeader),s=!0),s&&(this.dt=a)}}function d(e,t){var r=this.metrics,i=e[0],o=this;if(r&&i){var a=V(i);a&&(r.txSize=a)}this.startTime=(0,p.z)(),this.listener=function(e){try{\"abort\"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),(\"load\"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||\"function\"!=typeof t.onload)&&\"function\"==typeof o.end)&&o.end(t)}catch(e){try{n.emit(\"internal-error\",[e])}catch(e){}}};for(var s=0;s 1?e[1]=i:e.push(i)}else e[0]&&e[0].headers&&s(e[0].headers,n)&&(this.dt=n);function s(e,t){var r=!1;return t.newrelicHeader&&(e.set(\"newrelic\",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set(\"traceparent\",t.traceContextParentHeader),t.traceContextStateHeader&&e.set(\"tracestate\",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,p.z)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r,n=this.opts||{},i=this.target;\"string\"==typeof i?r=i:\"object\"==typeof i&&i instanceof Y?r=i.url:c._A?.URL&&\"object\"==typeof i&&i instanceof URL&&(r=i.href),T(this,r);var o=(\"\"+(i&&i instanceof Y&&i.method||n.method||\"GET\")).toUpperCase();this.params.method=o,this.txSize=V(n.body)||0}function A(t,r){var n;this.endTime=(0,p.z)(),this.params||(this.params={}),this.params.status=r?r.status:0,\"string\"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var o={txSize:this.txSize,rxSize:n,duration:(0,p.z)()-this.startTime};i(\"xhr\",[this.params,o,this.startTime,this.endTime,\"fetch\"],this,e.D.ajax)}function E(t){var r=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var o=0;o 2&&void 0!==arguments[2])||arguments[2];super(e,t,we.t,r),this.importAggregator()}}new class{constructor(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:(0,_.ky)(16);c._A?(this.agentIdentifier=t,this.sharedAggregator=new y({agentIdentifier:this.agentIdentifier}),this.features={},this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(m),Object.assign(this,(0,a.j)(this.agentIdentifier,e,e.loaderType||\"agent\")),this.start()):(0,l.Z)(\"Failed to initial the agent. Could not determine the runtime environment.\")}get config(){return{info:(0,t.C5)(this.agentIdentifier),init:(0,t.P_)(this.agentIdentifier),loader_config:(0,t.DL)(this.agentIdentifier),runtime:(0,t.OP)(this.agentIdentifier)}}start(){const t=\"features\";try{const r=n(this.agentIdentifier),i=[...this.desiredFeatures];i.sort(((t,r)=>e.p[t.featureName]-e.p[r.featureName])),i.forEach((t=>{if(r[t.featureName]||t.featureName===e.D.pageViewEvent){const n=function(t){switch(t){case e.D.ajax:return[e.D.jserrors];case e.D.sessionTrace:return[e.D.ajax,e.D.pageViewEvent];case e.D.sessionReplay:return[e.D.sessionTrace];case e.D.pageViewTiming:return[e.D.pageViewEvent];default:return[]}}(t.featureName);n.every((e=>r[e]))||(0,l.Z)(\"\".concat(t.featureName,\" is enabled but one or more dependent features has been disabled (\").concat((0,D.P)(n),\"). This may cause unintended consequences or missing data...\")),this.features[t.featureName]=new t(this.agentIdentifier,this.sharedAggregator)}})),(0,T.Qy)(this.agentIdentifier,this.features,t)}catch(e){(0,l.Z)(\"Failed to initialize all enabled instrument classes (agent aborted) -\",e);for(const e in this.features)this.features[e].abortHandler?.();const r=(0,T.fP)();return delete r.initializedAgents[this.agentIdentifier]?.api,delete r.initializedAgents[this.agentIdentifier]?.[t],delete this.sharedAggregator,r.ee?.abort(),delete r.ee?.get(this.agentIdentifier),!1}}}({features:[J,m,S,class extends h{static featureName=oe;constructor(t,r){if(super(t,r,oe,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;const n=this.ee;let i;(0,k.QU)(n),this.eventsEE=(0,k.em)(n),this.eventsEE.on(se,(function(e,t){this.bstStart=(0,p.z)()})),this.eventsEE.on(ae,(function(t,r){(0,s.p)(\"bst\",[t[0],r,this.bstStart,(0,p.z)()],void 0,e.D.sessionTrace,n)})),n.on(ce+ne,(function(e){this.time=(0,p.z)(),this.startPath=location.pathname+location.hash})),n.on(ce+ie,(function(t){(0,s.p)(\"bstHist\",[location.pathname+location.hash,this.startPath,this.time],void 0,e.D.sessionTrace,n)}));try{i=new PerformanceObserver((t=>{const r=t.getEntries();(0,s.p)(te,[r],void 0,e.D.sessionTrace,n)})),i.observe({type:re,buffered:!0})}catch(e){}this.importAggregator({resourceObserver:i})}},C,xe,B,class extends h{static featureName=de;constructor(e,r){if(super(e,r,de,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;if(!(0,t.OP)(e).xhrWrappable)return;try{this.removeOnAbort=new AbortController}catch(e){}let n,i=0;const o=this.ee.get(\"tracer\"),a=(0,k._L)(this.ee),s=(0,k.Lg)(this.ee),u=(0,k.BV)(this.ee),d=(0,k.Kf)(this.ee),f=this.ee.get(\"events\"),l=(0,k.u5)(this.ee),h=(0,k.QU)(this.ee),g=(0,k.Gm)(this.ee);function m(e,t){h.emit(\"newURL\",[\"\"+window.location,t])}function v(){i++,n=window.location.hash,this[ve]=(0,p.z)()}function b(){i--,window.location.hash!==n&&m(0,!0);var e=(0,p.z)();this[pe]=~~this[pe]+e-this[ve],this[ye]=e}function y(e,t){e.on(t,(function(){this[t]=(0,p.z)()}))}this.ee.on(ve,v),s.on(be,v),a.on(be,v),this.ee.on(ye,b),s.on(ge,b),a.on(ge,b),this.ee.buffer([ve,ye,\"xhr-resolved\"],this.featureName),f.buffer([ve],this.featureName),u.buffer([\"setTimeout\"+le,\"clearTimeout\"+fe,ve],this.featureName),d.buffer([ve,\"new-xhr\",\"send-xhr\"+fe],this.featureName),l.buffer([me+fe,me+\"-done\",me+he+fe,me+he+le],this.featureName),h.buffer([\"newURL\"],this.featureName),g.buffer([ve],this.featureName),s.buffer([\"propagate\",be,ge,\"executor-err\",\"resolve\"+fe],this.featureName),o.buffer([ve,\"no-\"+ve],this.featureName),a.buffer([\"new-jsonp\",\"cb-start\",\"jsonp-error\",\"jsonp-end\"],this.featureName),y(l,me+fe),y(l,me+\"-done\"),y(a,\"new-jsonp\"),y(a,\"jsonp-end\"),y(a,\"cb-start\"),h.on(\"pushState-end\",m),h.on(\"replaceState-end\",m),window.addEventListener(\"hashchange\",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener(\"load\",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener(\"popstate\",(function(){m(0,i>1)}),(0,O.m$)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}],loaderType:\"spa\"})})(),window.NRBA=o})(); window.jQuery || document.write(' ') CKEDITOR_BASEPATH='https://f1000research.com/js/vendor/ckeditor/' window.reactTheme = 'research'; window.MathJax = { CommonHTML: { linebreaks: { automatic: true } }, 'HTML-CSS': { linebreaks: { automatic: true } }, SVG: { linebreaks: { automatic: true } }, AuthorInit: function() { MathJax.Hub.Register.MessageHook('End Process', function () { let timeout = false; // holder for timeout id const delay = 250; // delay after event is \"complete\" to run callback const reflowMath = function() { const dispFormulas = document.querySelectorAll('.disp-formula.panel'); if (!dispFormulas) { return; } for (const dispFormula of dispFormulas) { const child = dispFormula.querySelector('.MathJax_Preview').nextSibling.firstChild; const isMultiline = MathJax.Hub.getAllJax(dispFormula)[0].root.isMultiline; if (dispFormula.offsetWidth < child.offsetWidth || isMultiline) { MathJax.Hub.Queue(['Rerender', MathJax.Hub, dispFormula]); } } }; window.addEventListener('resize', function() { clearTimeout(timeout); // clear the timeout timeout = setTimeout(reflowMath, delay); // start timing for event \"completion\" }); }); }, }; if (window.location.hash == '#_=_'){ window.location = window.location.href.split('#')[0] } !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function() {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)} ;if(!f._fbq)f._fbq=n; n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); fbq('init', '1641728616063202'); fbq('track', \"PixelInitialized\", {}); (function(h,o,t,j,a,r){ h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)}; h._hjSettings={hjid:2318163,hjsv:6}; a=o.getElementsByTagName('head')[0]; r=o.createElement('script');r.async=1; r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv; a.appendChild(r); })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv='); search file_upload Submit your research search menu close search Browse Gateways & Collections How to Publish Submit your Research My Submissions Article Guidelines Article Guidelines (New Versions) Open Data, Software and Code Guidelines Open Data and Accessible Source Materials Guidelines (HSS) Open Data, Software and Code Guidelines (PSE) Prepublication Checks Production Process Posters and Slides Guidelines Document Guidelines Article Processing Charges Peer Review Finding Article Reviewers About How it Works For Reviewers Our Advisors Policies Glossary FAQs For Developers Newsroom Contact My Research Submissions Content and Tracking Alerts My Details Sign In file_upload Submit your research { \"@context\": \"https://schema.org\", \"@type\": \"ScholarlyArticle\", \"mainEntityOfPage\": { \"@type\": \"WebPage\", \"@id\": \"https://f1000research.com/articles/14-622\" }, \"headline\": \"Therapeutic Use of Cannabis: Perceptions of Youth and Adults in Trujillo, Peru \", \"datePublished\": \"2025-06-25T15:22:50\", \"dateModified\": \"2026-01-29T06:17:05\", \"author\": [ { \"@type\": \"Person\", \"name\": \"Valeria Gómez-Amaya\" }, { \"@type\": \"Person\", \"name\": \"Amy Casanova-Coral\" }, { \"@type\": \"Person\", \"name\": \"Josué Campaña-Silva\" }, { \"@type\": \"Person\", \"name\": \"Jossuny Cubas-Namó\" }, { \"@type\": \"Person\", \"name\": \"Jesús Namay-Rebaza\" }, { \"@type\": \"Person\", \"name\": \"Genesis Camacho-Narvayes\" }, { \"@type\": \"Person\", \"name\": \"Walter Rojas-Villacorta\" } ], \"publisher\": { \"@type\": \"Organization\", \"name\": \"F1000Research\", \"logo\": { \"@type\": \"ImageObject\", \"url\": \"https://f1000research.com/img/AMP/F1000Research_image.png\", \"height\": 480, \"width\": 60 } }, \"image\": { \"@type\": \"ImageObject\", \"url\": \"https://f1000research.com/img/AMP/F1000Research_image.png\", \"height\": 1200, \"width\": 150 }, \"description\": \" Background In Peru, the legalization of Cannabis was given in 2017 and approved in 2019; however, there are discrepancies in the knowledge of the therapeutic use of this plant, causing rejection in its application as an alternative medicine. Methods The research was of a basic type with a quantitative approach and a non-experimental design, with a cross-sectional and descriptive scope. Non-probabilistic sampling was used and a total of 324 people (18 – 60 years old) were estimated as the sample. The instrument used was a virtual questionnaire consisting of closed questions with a KR-20 value of 0.825. Finally, the data were treated with descriptive statistics and frequency and percentage tables were used. Results Participants have a positive perception of the benefits of medical cannabis, although their knowledge of its therapeutic application and dosage is limited. The need for its use to be restricted to prescriptions by specialized physicians and backed by scientific evidence is highlighted. Despite having superficial information on applications in chronic diseases and cancer, there is a moderate acceptance of its regular use under medical supervision. Conclusion The population of Trujillo lacks knowledge about the medical benefits and applications of cannabis highlighting the need for educational campaigns. Although regulation is supported, concerns about safety and abuse remain. More studies should be conducted to obtain more accurate data. \" } { \"@context\": \"http://schema.org\", \"@type\": \"BreadcrumbList\", \"itemListElement\": [ { \"@type\": \"ListItem\", \"position\": \"1\", \"item\": { \"@id\": \"https://f1000research.com/\", \"name\": \"Home\" } }, { \"@type\": \"ListItem\", \"position\": \"2\", \"item\": { \"@id\": \"https://f1000research.com/browse/articles\", \"name\": \"Browse\" } }, { \"@type\": \"ListItem\", \"position\": \"3\", \"item\": { \"@id\": \"https://f1000research.com/articles/14-622/v1\", \"name\": \"Therapeutic Use of Cannabis: Perceptions of Youth and Adults in Trujillo,...\" } } ] } Home Browse Therapeutic Use of Cannabis: Perceptions of Youth and Adults in Trujillo,... ALL Metrics - Views Downloads Get PDF Get XML Cite How to cite this article Gómez-Amaya V, Casanova-Coral A, Campaña-Silva J et al. Therapeutic Use of Cannabis: Perceptions of Youth and Adults in Trujillo, Peru [version 1; peer review: awaiting peer review] . F1000Research 2025, 14 :622 ( https://doi.org/10.12688/f1000research.165597.1 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. Close Copy Citation Details Export Export Citation Sciwheel EndNote Ref. Manager Bibtex ProCite Sente EXPORT Select a format first Track Share ▬ ✚ Research Article Therapeutic Use of Cannabis: Perceptions of Youth and Adults in Trujillo, Peru [version 1; peer review: awaiting peer review] Valeria Gómez-Amaya https://orcid.org/0000-0003-2759-7970 1 , Amy Casanova-Coral 1 , Josué Campaña-Silva 1 , [...] Jossuny Cubas-Namó 1 , Jesús Namay-Rebaza 1 , Genesis Camacho-Narvayes 1 , Walter Rojas-Villacorta https://orcid.org/0000-0001-5833-7130 2 Valeria Gómez-Amaya https://orcid.org/0000-0003-2759-7970 1 , Amy Casanova-Coral 1 , [...] Josué Campaña-Silva 1 , Jossuny Cubas-Namó 1 , Jesús Namay-Rebaza 1 , Genesis Camacho-Narvayes 1 , Walter Rojas-Villacorta https://orcid.org/0000-0001-5833-7130 2 PUBLISHED 25 Jun 2025 Author details Author details 1 School of Medicine, Cesar Vallejo University Faculty of Medical Sciences, Trujillo, La Libertad, 13001, Peru 2 Department of Formative Research, Cesar Vallejo University, Trujillo, La Libertad, 13001, Peru Valeria Gómez-Amaya Roles: Conceptualization, Formal Analysis, Investigation, Methodology, Writing – Original Draft Preparation Amy Casanova-Coral Roles: Data Curation, Methodology, Software Josué Campaña-Silva Roles: Investigation, Methodology Jossuny Cubas-Namó Roles: Investigation, Software Jesús Namay-Rebaza Roles: Investigation Genesis Camacho-Narvayes Roles: Investigation, Writing – Original Draft Preparation Walter Rojas-Villacorta Roles: Funding Acquisition, Project Administration, Supervision, Writing – Review & Editing OPEN PEER REVIEW REVIEWER STATUS AWAITING PEER REVIEW Abstract Background In Peru, the legalization of Cannabis was given in 2017 and approved in 2019; however, there are discrepancies in the knowledge of the therapeutic use of this plant, causing rejection in its application as an alternative medicine. Methods The research was of a basic type with a quantitative approach and a non-experimental design, with a cross-sectional and descriptive scope. Non-probabilistic sampling was used and a total of 324 people (18 – 60 years old) were estimated as the sample. The instrument used was a virtual questionnaire consisting of closed questions with a KR-20 value of 0.825. Finally, the data were treated with descriptive statistics and frequency and percentage tables were used. Results Participants have a positive perception of the benefits of medical cannabis, although their knowledge of its therapeutic application and dosage is limited. The need for its use to be restricted to prescriptions by specialized physicians and backed by scientific evidence is highlighted. Despite having superficial information on applications in chronic diseases and cancer, there is a moderate acceptance of its regular use under medical supervision. Conclusion The population of Trujillo lacks knowledge about the medical benefits and applications of cannabis highlighting the need for educational campaigns. Although regulation is supported, concerns about safety and abuse remain. More studies should be conducted to obtain more accurate data. READ ALL READ LESS Keywords Therapeutic, Cannabis, Legislation, Medical use, Peruvians Corresponding Author(s) Walter Rojas-Villacorta ( [email protected] ) Close Corresponding author: Walter Rojas-Villacorta Competing interests: No competing interests were disclosed. Grant information: The author(s) declared that no grants were involved in supporting this work. Copyright: © 2025 Gómez-Amaya V et al . This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The author(s) is/are employees of the US Government and therefore domestic copyright protection in USA does not apply to this work. The work may be protected under the copyright laws of other jurisdictions when used in those jurisdictions. How to cite: Gómez-Amaya V, Casanova-Coral A, Campaña-Silva J et al. Therapeutic Use of Cannabis: Perceptions of Youth and Adults in Trujillo, Peru [version 1; peer review: awaiting peer review] . F1000Research 2025, 14 :622 ( https://doi.org/10.12688/f1000research.165597.1 ) First published: 25 Jun 2025, 14 :622 ( https://doi.org/10.12688/f1000research.165597.1 ) Latest published: 29 Jan 2026, 14 :622 ( https://doi.org/10.12688/f1000research.165597.2 )  There is a newer version of this article available. Suppress this message for one day. Introduction Since time immemorial, humankind has relied on the therapeutic use of medicinal plants based on knowledge acquired through experience and belief systems. These practices persist to the present day, and cannabis, a plant long used by our ancestors, is a case in point. The recent resurgence of interest in cannabis, driven in part by its legalization in several countries, has attracted a great deal of attention. 1 Widely known as marijuana, cannabis is the most widely consumed illicit drug worldwide. In recent years, there has been a marked increase in the number of countries that have legalized the use of cannabis for medicinal purposes. Examples include the Netherlands (2003), Italy (2007), Colombia (2015), Australia (2016), and Puerto Rico (2017), as well as 29 states in the United States. 2 , 3 The primary motivation behind legalization has been to facilitate the substance’s therapeutic and recreational use. 2 , 4 In the Netherlands, the utilization of cannabis has been confined to circumstances where conventional treatment has not yielded the anticipated response, a measure implemented to mitigate adverse effects. 3 In certain American countries, the legalization of marijuana for alternative medical purposes has been the subject of substantial controversy, as evidenced by the cases of Mexico, Colombia, and Argentina, where two generic drugs approved by the U.S. Food and Drug Administration are employed. 1 , 5 , 6 In Peru, the use of cannabis as a therapeutic alternative is a controversial issue. In 2017, the Peruvian government officially sanctioned the use of medical cannabis; however, the corresponding regulation was not approved until two years later. Acceptance of the use of medical cannabis as a treatment has been very variable, especially in the last 10 years. 2 In 2019, Law N° 30681 was approved, which regulates the medicinal and therapeutic use of cannabis and its derivatives, and establishes the General Directorate of Medicines, Inputs and Drugs (DIGEMID) as the competent authority to authorize the production, importation, commercialization and taxation of cannabis-related products. 7 The legalization of cannabis has raised concerns from a public health perspective, as its highly potent psychostimulant components are susceptible to abuse, leading to a number of problematic outcomes. 8 , 9 As a result, the public perception of cannabis remains controversial, especially among more conservative demographics who associate the plant with recreational use and the potential for adverse effects. A lack of accurate information about the use and benefits of medical cannabis has been noted among medical and non-medical personnel in Peru, and people often obtain information from non-scientific sources. 9 – 11 The lack of clear regulations on the medical use of cannabis raises doubts about its safety and efficacy. The proposal to legalize domestic cultivation of cannabis in the country has raised doubts about the ability to control THC and CBD levels in plants. Although THC and CBD have therapeutic benefits, particularly in alleviating the side effects of chemotherapy and chronic pain, the medical use of cannabis remains controversial. The lack of scientific evidence supporting its efficacy for certain diseases and the associated risks, such as addiction and potential mental disorders, contribute to the controversy. Without proper regulation, the safety and efficacy of cannabis-derived medicines may be called into question. It is crucial to establish clear guidelines to ensure that medical professionals and alternative medicine seekers have access to reliable information when using cannabis for treatment. 2 Research has demonstrated the potential benefits of THC and CBD on health. 12 However, the WHO does not currently recommend the medical use of CBD as an ingredient in pharmaceutical products due to insufficient studies demonstrating its safety. 12 The WHO states that CBD provides benefits in its natural state. Consequently, evaluating perceptions concerning cannabis utilization is instrumental in identifying salient concerns and knowledge gaps. This comprehensive assessment will facilitate the development of more efficacious public health policies and educational initiatives, thereby enhancing the informed and responsible utilization of medical cannabis, and ensuring its enhanced accessibility and safety. 13 The majority of studies concentrate on the medical knowledge of cannabis as a therapeutic alternative. 11 , 14 – 18 In the Peruvian context, this is also the case, as it is medical personnel who should possess sufficient knowledge to prescribe it. However, only a limited number of studies have focused on the perceptions of non-medical individuals, such as adolescents and young adults. However, insights from these individuals regarding their perceptions, knowledge, and experiences with cannabis use are crucial for comprehending behavioral patterns, acceptance levels, and emerging trends in cannabis consumption. 19 , 20 In this context, the following research question was posed: What is the perception of the use of cannabis as a therapeutic alternative among the inhabitants of the Peruvian city of Trujillo? The study was justified by the controversy of opinions generated by its legalization in Peru. Notwithstanding the prevailing stigma associated with its addictive potential and the prevailing cultural barriers that limit its medical application, the study seeks to underscore the significance of cannabis in the health field as a therapeutic option. 21 The objective of the study was to evaluate the knowledge and perception of cannabis as a therapeutic alternative in the population of Trujillo. This analysis is congruent with Sustainable Development Goal 3 (Health and Well-being), as it facilitates a more profound comprehension of how the population perceives cannabis use. The findings of this study can serve as a foundation for the development of more effective public health policies and programs, with the aim of promoting the physical and mental well-being of the Trujillo community. Methods Type, approach and research design This is a basic research study using a quantitative approach and a non-experimental, cross-sectional, descriptive design. This methodological framework enables a more precise evaluation of perceptions, safeguarding the integrity of the findings by precluding the manipulation of variables. Consequently, this design ensures a more accurate depiction of prevailing knowledge. Variable This will facilitate a comprehensive assessment of the perceptions and acceptance of the therapeutic use of cannabis by the population of Trujillo, 22 which will provide valuable information for the development of more effective health policies. Population, sample, and sampling The study population is constituted by the inhabitants of the city of Trujillo. The inclusion criteria include participants from diverse socioeconomic levels and cultural backgrounds, as well as individuals between the ages of 18 and 60, irrespective of gender, who are capable of responding to the study instruments. This criterion is intended to ensure the representativeness of the sample. Individuals under the age of 18, those with a documented history of serious mental disorders that may compromise their ability to participate, and those with a history of substance abuse that may interfere with the interpretation of the data will be excluded from the study. The sample size was calculated to be 324 participants, adjusted to a margin of error (e) of 5.45%, with a confidence interval (CI) of 95%, a z value of 1.96, and an estimated proportion of the population (p) of 0.5. The formula employed to estimate the sample proportion is as follows 23 : n = Z 2 × p × ( 1 – p ) / e 2 Data collection techniques The data were collected using structured surveys to ascertain the public perception of cannabis use in the city of Trujillo. The primary instrument employed in this study comprised closed-ended questions, designed to elicit personal data on the perception of cannabis use within the study sample. The surveys were then subjected to a process of validation by means of expert judgment. The data collection instrument was based on the survey proposed by Aliaga 24 with some modifications to adapt it to the objectives of the study. A new reliability was calculated using the KR-20 formula, yielding a value of 0.825, which is regarded as adequate according to Sampieri’s interpretation table. 25 The structured questionnaire comprised primarily closed questions with dichotomous response options, enabling the assessment of individuals’ perceptions regarding the therapeutic utilization of cannabis. The questionnaire will be divided into thematic blocks covering both knowledge and acceptance of medical cannabis, and will include questions to collect sociodemographic information on the participants (age, sex, educational level, and marital status), which will allow segmented analyses according to the different characteristics of the sample. In accordance with ethical research principles, the confidentiality of participants was guaranteed during the data collection process by providing them with prior information about the anonymous nature of the study and its purpose. The survey was created using Google Forms and shared on social network offering advantages in terms of accessibility, time, geographical reach, and cost. Written informed consent was obtained via a digital checkbox at the beginning of survey, in accordance with the principles of transparency, confidentiality, and voluntariness. The survey results were subsequently stored in a Microsoft Excel spreadsheet for analysis. Data analysis The results were organized and presented in tables of frequencies and percentages using descriptive statistics. This approach provided a clear and comprehensive understanding of the data, summarizing the key characteristics and trends observed in the surveyed population. Results The sociodemographic characteristics of the surveyed population indicate that most of the subjects are young (59.6%), with a high level of education, usually university level. In terms of sex, the population is predominantly female (56.2%), and in terms of marital status, most of the subjects are single (81.2%). As shown in Table 2 , the survey results indicate a lack of general knowledge about the use of cannabis as a therapeutic alternative. While some respondents expressed being aware of its benefits and therapeutic applications, the majority showed a lack of knowledge about its presentations, recommended doses and harmful effects. Regarding the perception of Peruvian and foreign legislation, a minority of those surveyed said they were unaware of the subject. Approximately, a little more than half of the respondents expressed the belief that cannabis consumption can generate addiction and have psychoactive effects. Finally, a minority of respondents believed that medical cannabis could be therapeutically useful for children, while the majority did not consider it appropriate for this group. As demonstrated in Table 3 , the majority of respondents expressed the opinion that only specialized physicians should prescribe medical cannabis and that it is safe if used responsibly. However, opinions were divided on its overall safety and potential health risks. The majority of respondents expressed their belief that pharmacists should possess a comprehensive understanding of medical cannabis, acknowledging the potential for abuse. There was a general consensus on the need to better inform the public and support for legalization with scientific backing. However, opinions were divided on whether the use of medical cannabis can lead to the use of other drugs and whether it is a viable therapeutic alternative. Discussion The research results indicate that sociodemographic characteristics have the potential to influence perceptions and acceptance of cannabis for medical use (see Table 1 ). The majority of participants were young and, consistent with other research, younger generations are more open to discussing and adopting alternative treatments such as medical cannabis. They are more open to new ideas and trends, which may lead to greater acceptance of the therapeutic use of cannabis, which was previously surrounded by taboos and misconceptions in previous generations. 11 , 26 This inclination toward novel approaches may be attributed to the greater accessibility of knowledge through social networks, characteristic of both young people and adults. In terms of educational level, most participants had attained a university level, suggesting that they may possess a broader understanding of the subject, which could lead to a greater openness to accepting controversial issues, such as the use of medical cannabis. 20 The majority of the participants possessed a university education, indicating a more extensive understanding of the subject matter and a higher propensity for acceptance of medical cannabis. However, it should be noted that this is not a definitive factor. 18 , 27 Similarly, a lack of accurate information influences the perception of cannabis use. In this sense, the absence of educational campaigns focused on the therapeutic use of cannabis contributes to this misinformation, reflecting the urgent need to address this knowledge gap among both the general population and healthcare professionals. 17 The accessibility of the media and social networks, which often present contradictory or non-scientifically based information, which can generate confusion among the population and unequal perceptions about the therapeutic use of cannabis. Added to this is the fact that part of the population accepts it while others question it due to the lack of scientifically validated information. 28 Table 1. Frequencies and sociodemographic percentages of the surveyed public. Characteristics Frequency (n) Percentage (%) Age Young (18–26 years) 193 58.5 Adult (24–59 years) 131 39.7 Older Adult (> 60 years) 6 1.8 Total 330 100 Level of Education No educated 1 0.3 Secondary school 54 16.4 Technical studies 48 14.5 University 227 68.8 Total 330 100 Gender Female 184 55.8 Male 146 44.2 Total 330 100 Marital status Single 269 81.5 Married 61 18.5 Total 330 100 With regard to the utilization of medical cannabis (see Table 2 ), it was noted that 50.3% of respondents indicated a deficiency in knowledge concerning the benefits of medical cannabis, while 69.7% indicated a lack of knowledge about the risks associated with its use in terms of harmful effects. This observation suggests a general lack of knowledge about the benefits of medical cannabis among respondents, which may be related to the limited scientific evidence supporting its use. 29 As Black et al. note, the paucity of scientific evidence supporting the efficacy of medical cannabis for depressive disorders reinforces the notion that the benefits of medical cannabis are not widely understood and have not been demonstrated in all cases. 30 This suggests that, due to the lack of conclusive evidence, both the general population and healthcare professionals may have difficulty understanding or communicating the potential benefits of cannabis in the medical setting. Table 2. Distribution of frequencies and percentages on the perception of knowledge of cannabis sativa as a therapeutic alternative in the population of Trujillo. Items Respondents’ answers (n = 330; 100.0%) Yes n (%) No N (%) Do you know the diseases that can be treated with medical cannabis? 168 (50.9) 162 (49.1) Do you know the therapeutic benefits of using medical cannabis? 164 (49.7) 166 (50.3) Do you have knowledge about the benefits of cannabis oil? 143 (43.3) 187 (56.7) Do you know the different presentations of cannabis? 127 (38.5) 203 (61.5) Do you know the recommended doses to consume when using medical cannabis? 58 (17.6) 272 (82.4) Do you know the harmful effects of using medical cannabis? 100 (30.3) 230 (69.7) Do you know if medical cannabis can be used by people with psychiatric conditions? 108 (32.7) 222 (67.3) Do you have any idea if everyone has access to medical cannabis? 59 (17.9) 271 (82.1) Do you know if access to medical cannabis is legal and safe in Peru? 85 (25.8) 245 (74.2) According to current legislation? Do you know how medical cannabis is distributed? 56 (17) 274 (83) Do you know if medical cannabis is being legalized worldwide? 62 (18.8) 268 (81.2) Do you believe that the use of medical cannabis can cause neuropsychiatric disorders? 115 (34.8) 215 (65.2) Do you believe that the use of medical cannabis can lead to addiction? 169 (51.2) 161 (48.8) Do you have any opinion on whether or not medical cannabis can be used therapeutically in children? 111 (33.6) 219 (66.4) The research reveals a considerable gap in knowledge about cannabis legalization, with less than a quarter of respondents informed about it, suggesting a lack of access to information or a lack of interest in the topic. In contrast, studies in countries such as the United States show that the social and legal environment influences attitudes towards cannabis use, with greater acceptance in contexts of legalization, according to Yu et al. 31 Regarding the perception that cannabis can cause addiction, the results are divided: 51.2% of respondents expressed the opinion that cannabis use can cause addiction, a perception supported by Hoch et al. who indicate that a large proportion of the world’s population suffers from cannabis use disorders. 32 Furthermore, Compton et al. suggest that around 30% of users are likely to become dependent. 33 However, this represents only a fraction of the world’s population, suggesting that not all users develop dependence or related disorders. As demonstrated in Table 3 , there is a clear division of opinion regarding the therapeutic use of cannabis. According to Sznitman, 34 many of these concerns stem from the lack of solid scientific evidence, which significantly influences public acceptance of cannabis as a therapeutic option. The results of this study reflect this division, with 46.4% of participants in favor of its use for therapeutic purposes, compared to 53.6% who disagree. This division corresponds with the need for evidence-based legalization, with 90.6% of participants stressing the importance of scientific support. However, Montero et al. 35 have pointed out that current support for medicinal cannabinoids remains limited and is based on preliminary or inconclusive data. Furthermore, the preponderance of respondents expressed strong support for the establishment of regulated frameworks, with an overwhelming majority agreeing that cannabis prescribing should be reserved exclusively for specialized physicians (86.7%) and that pharmacists should be required to provide comprehensive information on its use (90.3%). 36 These results underscore the prevailing societal inclination toward safety and professional standards, a sentiment that persists even among those who are receptive to its legalization. Table 3. Distribution of frequencies and percentages on the acceptance of Cannabis as a therapeutic alternative in the population of Trujillo. Items Respondents’ answer (n = 330; 100.0%) Yes n (%) No n (%) Should medical cannabis only be prescribed by specialists in your opinion? 286 (86.7) 44 (13.3) Is medical cannabis safe in your opinion? 183 (55.5) 147 (44.5) As long as it is used responsibly, do you think medical cannabis is safe? 294 (89.1) 36 (10.9) Do you think therapeutic use of medical cannabis harms health? 98 (29.7) 232 (70.3) Do you think it is important for pharmacists to provide adequate information about medical cannabis? 298 (90.3) 32 (9.7) Do you think people tend to abuse medical cannabis? 226 (68.5) 104 (31.5) Do you think people should be better educated about medical cannabis? 301 (91.2) 29 (8.8) Do you think that legalizing the therapeutic use of medical cannabis needs to be based on scientific evidence? 299 (90.6) 31 (9.4) Do you think medical cannabis should be allowed to be used without a prescription? 87 (26.4) 243 (73.6) Do you think that using medical cannabis can be a gateway to using other drugs? 192 (58.2) 138 (41.8) Have you ever considered cannabis as a therapeutic alternative? 153 (46.4) 177 (53.6) The results are important since they facilitate updating knowledge about cannabis in the population of Trujillo., in addition to contributing to the achievement of the Sustainable Development Goals. A comprehensive understanding of behaviors and knowledge concerning cannabis use is instrumental in formulating health policies that promote its safe and responsible use. These policies aim to identify and mitigate the stigmas and prejudices associated with its use, thereby fostering a more equitable and inclusive society. However, the study is not without limitations. Firstly, non-probabilistic sampling was employed, which precludes the extension of the results to the total population of Trujillo. Secondly, while the study assessed perceptions of medical cannabis, it did not analyze other contextual factors, such as cultural or socioeconomic influences, which could provide a more comprehensive perspective. Finally, the reliance on survey responses may introduce response biases or limitations in the accuracy of the results. Ethical considerations This study was conducted in accordance with the Code of Ethics guidelines established by César Vallejo University and the provisions of Rector’s Resolution No. 760-2007/UCV. 37 The research was also approved by the Research Directorate’s Ethics Committee with an unnumbered ruling dated February 18, 2025. The study adhered to the principles outlined in the Declaration of Helsinki, ensuring respect for the autonomy, integrity, and dignity of the participants. Surveys were administered using Google Forms to allow for efficient, accessible data collection. To ensure compliance with the ethical principles of transparency and voluntariness, written informed consent was requested from participants via a checkbox before the survey began. This mechanism ensured that participants understood the purpose and scope of the study before providing their responses. Authors’ contributions Valeria Gómez-Amaya: Conceptualization, formal analysis, investigation, visualization, writing – original draft preparation. Amy Casanova-Coral: Conceptualization, data collection, investigation and methodology. Josué Campaña-Silva: Conceptualization, data collection, investigation and methodology. Jossuny Cubas-Namó: Conceptualization, data collection and investigation. Jesús Namay-Rebaza: Conceptualization, data collection and investigation. Genesis Camacho-Narvayes: Conceptualization, data collection and investigation. Walter Rojas-Villacorta: Writing – review & editing, Supervision, Validation, Writing and funding acquisition. Data availability The data used in this study are available on Zenodo repository, under the title: “Database: Therapeutic Use of Cannabis: Perceptions of Youth and Adults in Trujillo, Peru” available from: DOI: https://doi.org/10.5281/zenodo.15450746 . 38 They can be freely accessed and downloaded according to the terms and conditions of the platform. Data are available under the terms of the Creative Commons Attribution 4.0 International (CC-BY 4.0). Extended data Zenodo: Database: Therapeutic Use of Cannabis: Perceptions of Youth and Adults in Trujillo, Peru, https://doi.org/10.5281/zenodo.15450746 . 38 This project contains the following underlying data: 1. Comité de ética de la Dirección de Investigación-Canabis.pdf (in Spanish) 2. DATABASE-CANNABIS.xlsx 3. Informed Consent in Spanish and English-Canabis.docx Data are available under the terms of the Creative Commons Attribution 4.0 International (CC-BY 4.0). Acknowledgements The authors are grateful to Universidad Cesar Vallejo for allowing the development of the research and its respective financing for the publication of the article. References 1. Kochen S: Medical cannabis. Salud Colect. 2022; 18 : e3991. Publisher Full Text 2. Mendoza-Chuctaya G: Legalisation of medicinal marijuana in Perú. Rev Colomb Psiquiatr (Engl). 2020; 51 (1): 4–5. PubMed Abstract | Publisher Full Text 3. Carracedo S: Consideraciones bioéticas sobre la relación médico-paciente para el uso del cannabis medicinal en Perú. Rev. Peru Med. Exp. Salud Publica. 2019; 36 (2): 334–340. PubMed Abstract | Publisher Full Text 4. Bougea A, Koros C, Simitsi AM, et al. : Medical cannabis as an alternative therapeutics for Parkinsons’ disease: Systematic review. Complement. Ther. Clin. Pract. 2020; 39 (101154): 101154. PubMed Abstract | Publisher Full Text 5. Cubillos Sánchez PA: Cannabis for medical and scientific purposes: the Colombian landscape. Colomb. J. Anesthesiol. 2020; 49 (2). Publisher Full Text 6. Covarrubias-Torres N: Uso medicinal de la Marihuana. Anestesia en México. 2019; 31 (2): 49–58. Accessed March 4, 2025. Reference Source 7. MINSA: Decreto Supremo N.° 005-2019-SA. Gob.pe. 25 de febrero de 2019. Accessed March 4, 2025. Reference Source 8. Rodríguez-Venegas E d l C, Fontaine-Ortiz JE: Situación actual de Cannabis sativa, beneficios terapéuticos y reacciones adversas. Rev habanera cienc médicas. 2020; 19 (6). Accessed March 4, 2025. Reference Source 9. Wong Salgado PAD: Potencial terapéutico de los perfiles de cannabinoides identificados en cultivares de cannabis en Perú. Universidad Nacional Mayor de San Marcos; 2024. Accessed March 4, 2025. Reference Source 10. Reyes Astudillo CP: Representaciones Sociales En Torno al Uso de Cannabis En Pacientes Con Dolor Crónico de Lima Metropolitana. Universidad San Ignacio de Loyola; 2020. Accessed March 5, 2025. Reference Source 11. Soto-Cáceres VA: Cannabis medicinal: Conocimientos y actitudes en médicos de hospitales de una Región Peruana: Medicinal cannabis: Knowledge and attitudes in doctors of hospitals in a Peruvian Region. Rev.exp.med. 2022; 8 (3). Publisher Full Text 12. Narciso Enrique LS: Aspectos químicos y farmacológicos de los componentes de Cannabis sativa “marihuana.” UCV - SCIENTIA. 2017; 7 (Suplemento 1): 163–163. Accessed March 5, 2025. Reference Source 13. WHO: Drugs (psychoactive): Cannabidiol (compound of cannabis). Who.int. Accessed March 5, 2025. Reference Source 14. Syed SA, Singh J, Elkholy H, et al. : International perspective on physician knowledge, attitude and practices related to medical cannabis. medRxiv. 2023. PubMed Abstract | Publisher Full Text | Free Full Text 15. Adler L, Zacay G, Schonmann Y, et al. : Primary care physicians’ attitudes and knowledge regarding medical cannabis and willingness to prescribe it: the Israeli experience. Fam. Pract. 2022; 39 (1): 59–64. PubMed Abstract | Publisher Full Text 16. Cheng KYC, Harnett JE, Davis SR, et al. : Healthcare professionals’ perspectives on the use of medicinal cannabis to manage chronic pain: A systematic search and narrative review. Pain Pract. 2022; 22 (8): 718–732. PubMed Abstract | Publisher Full Text | Free Full Text 17. Quintanilla Rojas GR: Características Del Comportamiento Del Consumidor de Productos Derivados Del Cannabis Para Uso Medicinal de Los Pacientes de La Asociación Marihuana Medicinal Trujillo-Perú. Universidad Privada del Norte; 2020. Reference Source 18. Camposano De la Cruz CJ, Castro Meneses MC: Nivel de Conocimiento y Actitud Sobre El Uso Medicinal de Cannabis En Médicos Cirujanos Del Instituto Regional de Enfermedades Neoplásicas Del Centro - Junín, 2024. Universidad Continental; 2024. Accessed March 5, 2025. Reference Source 19. Rey-Brandariz J, Teijeiro A, Pérez-Ríos M, et al. : Percepción del consumo de cannabis en población adolescente: metasíntesis de estudios cualitativos. Gac. Sanit. 2024; 38 (102410): 102410. PubMed Abstract | Publisher Full Text 20. Bottorff JL, Bissell LJL, Balneaves LG, et al. : Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study. Harm Reduct. J. 2013; 10 (1): 2. PubMed Abstract | Publisher Full Text | Free Full Text 21. Decreto Supremo que aprueba el Reglamento que regula el uso medicinal y terapéutico del cannabis y sus derivados - DECRETO SUPREMO - N° 004-2023-SA - Elperuano.pe. Accessed March 5, 2025. Reference Source 22. Oyola-García AE: La variable. Rev Cuerpo Med HNAAA. 2021; 14 (1): 90–93. Publisher Full Text 23. Ahmed SK: How to choose a sampling technique and determine sample size for research: A simplified guide for researchers. Oral Oncol. Rep. 2024; 12 (100662): 100662. Publisher Full Text 24. Aliaga Naula EA, Moreno Corne MP: Creencias, actitudes y conocimientos sobre el uso de cannabis medicinal en los usuarios de la Farmacia Superfarma Chilca-2023. Universidad Privada de Huancayo Franklin Roosevelt; 2024. Accessed March 5, 2025. Reference Source 25. Sampieri RH, Collado CF, Lucio PB, et al. : Metodología de la investigación.2014. 26. Ccami-Bernal F, Rojas-Miliano C, Soriano-Moreno DR, et al. : Factores asociados con el consumo de plantas medicinales para la prevención de COVID-19 en población peruana: un estudio transversal. Rev. Peru Med. Exp. Salud Publica. 2024; 41 (1): 37–45. PubMed Abstract | Publisher Full Text | Free Full Text 27. Corroto F, Gamarra Torres OA, Macía MJ: Different patterns in medicinal plant use along an elevational gradient in northern Peruvian Andes. J. Ethnopharmacol. 2019; 239 (111924): 111924. PubMed Abstract | Publisher Full Text 28. García Henares JF, de Santiago Moraga J : Evidencia científica actualizada del tratamiento con cannabis medicinal en pacientes con dolor crónico. Rev. Soc. Esp. Dolor. 2022. Publisher Full Text 29. Baral A, Morales V, Diggs BNA, et al. : Perceptions, attitudes, and knowledge of cannabis and its use: A qualitative study among Herbal Heart Study young adult cannabis consumers in south Florida. Prev. Med. Rep. 2024; 37 : 102574. PubMed Abstract | Publisher Full Text | Free Full Text 30. Black N, Stockings E, Campbell G, et al. : Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis. Lancet Psychiatry. 2019; 6 (12): 995–1010. PubMed Abstract | Publisher Full Text | Free Full Text 31. Yu B, Chen X, Chen X, et al. : Marijuana legalization and historical trends in marijuana use among US residents aged 12-25: results from the 1979-2016 National Survey on drug use and health. BMC Public Health. 2020; 20 (1): 156. PubMed Abstract | Publisher Full Text | Free Full Text 32. Hoch E, Volkow ND, Friemel CM, et al. : Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits. Eur. Arch. Psychiatry Clin. Neurosci. 2024; 275 : 281–292. PubMed Abstract | Publisher Full Text | Free Full Text 33. Compton WM, Einstein EB, Han B: 12-month prevalence estimates of substance use disorders using DSM-5 versus DSM-IV criteria among U.S. nonelderly adults with substance use. Am. J. Psychiatry. 2024; 181 (11): 1018–1021. PubMed Abstract | Publisher Full Text 34. Sznitman SR, Zolotov Y: Cannabis for therapeutic purposes and public health and safety: a systematic and critical review. Int. J. Drug Policy. 2015; 26 (1): 20–29. PubMed Abstract | Publisher Full Text 35. Montero-Oleas N, Arevalo-Rodriguez I, Nuñez-González S, et al. : Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews. BMC Complement Med Ther. 2020; 20 (1): 12. PubMed Abstract | Publisher Full Text | Free Full Text 36. Levinsohn EA, Hill KP: Clinical uses of cannabis and cannabinoids in the United States. J. Neurol. Sci. 2020; 411 : 116717. PubMed Abstract | Publisher Full Text 37. Vistos: el ON, Remitido Por el DJSR, Vicerrector de I. Trujillo, de julio de 2022. Edu.pe. 2022. Accessed March 5, 2025. Reference Source 38. Gómez-Amaya V, Rojas-Villacorta W: Database: Therapeutic Use of Cannabis: Perceptions of Youth and Adults in Trujillo, Peru. Zenodo. 2025. Publisher Full Text Comments on this article Comments (0) Version 2 VERSION 2 PUBLISHED 25 Jun 2025 ADD YOUR COMMENT Comment Author details Author details 1 School of Medicine, Cesar Vallejo University Faculty of Medical Sciences, Trujillo, La Libertad, 13001, Peru 2 Department of Formative Research, Cesar Vallejo University, Trujillo, La Libertad, 13001, Peru Valeria Gómez-Amaya Roles: Conceptualization, Formal Analysis, Investigation, Methodology, Writing – Original Draft Preparation Amy Casanova-Coral Roles: Data Curation, Methodology, Software Josué Campaña-Silva Roles: Investigation, Methodology Jossuny Cubas-Namó Roles: Investigation, Software Jesús Namay-Rebaza Roles: Investigation Genesis Camacho-Narvayes Roles: Investigation, Writing – Original Draft Preparation Walter Rojas-Villacorta Roles: Funding Acquisition, Project Administration, Supervision, Writing – Review & Editing Competing interests No competing interests were disclosed. Grant information The author(s) declared that no grants were involved in supporting this work. Article Versions (2) version 2 Revised Published: 29 Jan 2026, 14:622 https://doi.org/10.12688/f1000research.165597.2 version 1 Published: 25 Jun 2025, 14:622 https://doi.org/10.12688/f1000research.165597.1 Copyright © 2025 Gómez-Amaya V et al . This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The author(s) is/are employees of the US Government and therefore domestic copyright protection in USA does not apply to this work. The work may be protected under the copyright laws of other jurisdictions when used in those jurisdictions. Download Export To Sciwheel Bibtex EndNote ProCite Ref. Manager (RIS) Sente metrics Views Downloads F1000Research - - PubMed Central info_outline Data from PMC are received and updated monthly. - - Citations open_in_new 0 open_in_new 0 open_in_new SEE MORE DETAILS CITE how to cite this article Gómez-Amaya V, Casanova-Coral A, Campaña-Silva J et al. Therapeutic Use of Cannabis: Perceptions of Youth and Adults in Trujillo, Peru [version 1; peer review: awaiting peer review] . F1000Research 2025, 14 :622 ( https://doi.org/10.12688/f1000research.165597.1 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS track receive updates on this article Track an article to receive email alerts on any updates to this article. TRACK THIS ARTICLE Share Open Peer Review Current Reviewer Status: AWAITING PEER REVIEW AWAITING PEER REVIEW ? Key to Reviewer Statuses VIEW HIDE Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Comments on this article Comments (0) Version 2 VERSION 2 PUBLISHED 25 Jun 2025 ADD YOUR COMMENT Comment keyboard_arrow_left keyboard_arrow_right Open Peer Review Reviewer Status AWAITING PEER REVIEW Comments on this article All Comments (0) Add a comment Sign up for content alerts Sign Up You are now signed up to receive this alert Browse by related subjects Alongside their report, reviewers assign a status to the article: Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions Adjust parameters to alter display View on desktop for interactive features Includes Interactive Elements View on desktop for interactive features Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Stay Updated Sign up for content alerts and receive a weekly or monthly email with all newly published articles Register with F1000Research Already registered? Sign in Not now, thanks close PLEASE NOTE If you are an AUTHOR of this article, please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a “User Comment”. If you are a REVIEWER of this article, please check that you have signed in with the account associated with this article and then go to your account to submit your report, please do not post your review here. If you do not have access to your original account, please contact us . All commenters must hold a formal affiliation as per our Policies . The information that you give us will be displayed next to your comment. User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the User Comment Terms and Conditions . Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available. I accept the User Comment Terms and Conditions Please confirm that you accept the User Comment Terms and Conditions. Affiliation ✕ refresh Please enter your institution. Note: To add your institution or organisation, start typing the name and then select the correct name from the list. Where applicable, the name will appear in both the original language and in English. Do not paste in the name. If the name does not appear in the drop-down list, we will display the information you have entered. ✕ refresh Country/Region * USA UK Canada China France Germany Afghanistan Aland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory British Virgin Islands Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Cook Islands Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Federated States of Micronesia Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and Mcdonald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo (Serbia and Montenegro) Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Minor Outlying Islands of the United States Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Korea North Macedonia Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Helena Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Is South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand The Gambia The Netherlands Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu UK USA Uganda Ukraine United Arab Emirates United States Virgin Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam Wallis and Futuna West Bank and Gaza Strip Western Sahara Yemen Zambia Zimbabwe Please select your country/region. You must enter a comment. Competing Interests Please disclose any competing interests that might be construed to influence your judgment of the article's or peer review report's validity or importance. Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Please state your competing interests The comment has been saved. An error has occurred. Please try again. Cancel Post var lTitle = \"Therapeutic Use of Cannabis: Perceptions...\".replace(\"'\", ''); var linkedInUrl = \"http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/14-622/v1\" + \"&title=\" + encodeURIComponent(lTitle) + \"&summary=\" + encodeURIComponent('Read the article by '); var deliciousUrl = \"https://del.icio.us/post?url=https://f1000research.com/articles/14-622/v1&title=\" + encodeURIComponent(lTitle); var redditUrl = \"http://reddit.com/submit?url=https://f1000research.com/articles/14-622/v1\" + \"&title=\" + encodeURIComponent(lTitle); linkedInUrl += encodeURIComponent('Gómez-Amaya V et al.'); var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; var addthis_config = { ui_offset_top: offsetTop, services_compact : \"facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com\", services_expanded : \"facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com\", services_custom : [ { name: \"LinkedIn\", url: linkedInUrl, icon:\"/img/icon/at_linkedin.svg\" }, { name: \"Mendeley\", url: \"http://www.mendeley.com/import/?url=https://f1000research.com/articles/14-622/v1/mendeley\", icon:\"/img/icon/at_mendeley.svg\" }, { name: \"Reddit\", url: redditUrl, icon:\"/img/icon/at_reddit.svg\" }, ] }; var addthis_share = { url: \"https://f1000research.com/articles/14-622\", templates : { twitter : \"Therapeutic Use of Cannabis: Perceptions of Youth and Adults.... Gómez-Amaya V et al., published by \" + \"@F1000Research\" + \", https://f1000research.com/articles/14-622/v1\" } }; if (typeof(addthis) != \"undefined\"){ addthis.addEventListener('addthis.ready', checkCount); addthis.addEventListener('addthis.menu.share', checkCount); } $(\".f1r-shares-twitter\").attr(\"href\", \"https://twitter.com/intent/tweet?text=\" + addthis_share.templates.twitter); $(\".f1r-shares-facebook\").attr(\"href\", \"https://www.facebook.com/sharer/sharer.php?u=\" + addthis_share.url); $(\".f1r-shares-linkedin\").attr(\"href\", addthis_config.services_custom[0].url); $(\".f1r-shares-reddit\").attr(\"href\", addthis_config.services_custom[2].url); $(\".f1r-shares-mendelay\").attr(\"href\", addthis_config.services_custom[1].url); function checkCount(){ setTimeout(function(){ $(\".addthis_button_expanded\").each(function(){ var count = $(this).text(); if (count !== \"\" && count != \"0\") $(this).removeClass(\"is-hidden\"); else $(this).addClass(\"is-hidden\"); }); }, 1000); } close How to cite this report {{reportCitation}} Cancel Copy Citation Details $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');}); $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');}); $.get(\"/articles/acj/165597/182285\") new F1000.Clipboard(); new F1000.ThesaurusTermsDisplay(\"articles\", \"article\", \"182285\"); $(document).ready(function() { $( \"#frame1\" ).on('load', function() { var mydiv = $(this).contents().find(\"div\"); var h = mydiv.height(); console.log(h) }); var tooltipLivingFigure = jQuery(\".interactive-living-figure-label .icon-more-info\"), titleLivingFigure = tooltipLivingFigure.attr(\"title\"); tooltipLivingFigure.simpletip({ fixed: true, position: [\"-115\", \"30\"], baseClass: 'small-tooltip', content:titleLivingFigure + \" \" }); tooltipLivingFigure.removeAttr(\"title\"); $(\"body\").on(\"click\", \".cite-living-figure\", function(e) { e.preventDefault(); var ref = $(this).attr(\"data-ref\"); $(this).closest(\".living-figure-list-container\").find(\"#\" + ref).fadeIn(200); }); $(\"body\").on(\"click\", \".close-cite-living-figure\", function(e) { e.preventDefault(); $(this).closest(\".popup-window-wrapper\").fadeOut(200); }); $(document).on(\"mouseup\", function(e) { var metricsContainer = $(\".article-metrics-popover-wrapper\"); if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) { $(\".article-metrics-close-button\").click(); } }); var articleId = $('#articleId').val(); if($(\"#main-article-count-box\").attachArticleMetrics) { $(\"#main-article-count-box\").attachArticleMetrics(articleId, { articleMetricsView: true }); } }); var figshareWidget = $(\".new_figshare_widget\"); if (figshareWidget.length > 0) { window.figshare.load(\"f1000\", function(Widget) { // Select a tag/tags defined in your page. In this tag we will place the widget. _.map(figshareWidget, function(el){ var widget = new Widget({ articleId: $(el).attr(\"figshare_articleId\") //height:300 // this is the height of the viewer part. [Default: 550] }); widget.initialize(); // initialize the widget widget.mount(el); // mount it in a tag that's on your page // this will save the widget on the global scope for later use from // your JS scripts. This line is optional. //window.widget = widget; }); }); } close Error Close Add Reset F1000.MICROSERVICES.AFFILIATION = ''; $(document).ready(function () { $('.js-affiliations-form').each((index, form) => { new AffiliationForm({ formId: form.id, institutionErrorSelector: '.comment-enter-institution', departmentErrorSelector: '.comment-enter-department', placeSelector: '.js-add-comment-place', stateSelector: '.js-add-comment-state', zipCodeSelector: '.js-add-comment-zipcode', countrySelector: '.js-add-comment-country', countryErrorSelector: '.comment-enter-country', }); }); }); $(document).ready(function () { var reportIds = { \"464901\": 0, \"464900\": 0, \"464899\": 0, \"464898\": 0, \"464897\": 0, \"464896\": 0, \"460567\": 0, \"460566\": 0, \"460565\": 0, \"460564\": 0, \"460573\": 0, \"460572\": 0, \"460571\": 0, \"460570\": 0, \"460569\": 0, \"460568\": 0, \"415022\": 0, \"415023\": 0, \"415020\": 0, \"415021\": 0, \"415018\": 0, \"415019\": 0, \"415017\": 0, \"415026\": 0, \"415024\": 0, \"415025\": 0, \"401734\": 0, \"401735\": 0, \"401732\": 0, \"401733\": 0, \"401730\": 0, \"401731\": 0, \"401738\": 0, \"401739\": 0, \"401736\": 0, \"401737\": 0, \"471653\": 0, \"471652\": 0, \"471651\": 0, \"471650\": 0, \"471711\": 0, \"471710\": 0, \"471709\": 0, \"471708\": 0, \"471707\": 0, \"406950\": 0, \"406951\": 0, \"406948\": 0, \"406949\": 0, \"406946\": 0, \"406947\": 0, \"471713\": 0, \"406944\": 0, \"471712\": 0, \"406945\": 0, \"406952\": 0, \"406953\": 0, \"395972\": 0, \"395973\": 0, \"395969\": 0, \"469711\": 0, \"395982\": 0, \"469710\": 0, \"395983\": 0, \"395980\": 0, \"395981\": 0, \"395979\": 0, \"458198\": 0, \"469719\": 0, \"458199\": 0, \"469718\": 0, \"458196\": 0, \"469717\": 0, \"458197\": 0, \"469716\": 0, \"469715\": 0, \"458195\": 0, \"469714\": 0, \"469713\": 0, \"395984\": 0, \"469712\": 0, \"395985\": 0, \"458204\": 0, \"458202\": 0, \"458203\": 0, \"458200\": 0, \"458201\": 0, \"463079\": 0, \"463087\": 0, \"463086\": 0, \"463085\": 0, \"463084\": 0, \"463083\": 0, \"463082\": 0, \"463081\": 0, \"463080\": 0, \"410102\": 0, \"410103\": 0, \"410100\": 0, \"410101\": 0, \"410098\": 0, \"410099\": 0, \"463088\": 0, \"464895\": 0, \"464894\": 0, \"464893\": 0, \"464892\": 0, \"410106\": 0, \"410107\": 0, \"410104\": 0, \"410105\": 0, }; $(\".referee-response-container,.js-referee-report\").each(function(index, el) { var reportId = $(el).attr(\"data-reportid\"), reportCount = reportIds[reportId] || 0; $(el).find(\".comments-count-container,.js-referee-report-views\").html(reportCount); }); var uuidInput = $(\"#article_uuid\"), oldUUId = uuidInput.val(), newUUId = \"ab0dfef3-1632-4d44-afe6-409b5ee00017\"; uuidInput.val(newUUId); $(\"a[href*='article_uuid=']\").each(function(index, el) { var newHref = $(el).attr(\"href\").replace(oldUUId, newUUId); $(el).attr(\"href\", newHref); }); }); An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing. Browse Gateways Collections How it Works Contact For Developers Cookie Notice Privacy Notice RSS Submit Your Research Follow us © 2012-2026 F1000 Research Ltd. ISSN 2046-1402 | Legal | Partner of Research4Life • CrossRef • ORCID • FAIRSharing R.templateTests.simpleTemplate = R.template(' $text $text $text $text $text '); R.templateTests.runTests(); var F1000platform = new F1000.Platform({ name: \"f1000research\", displayName: \"F1000Research\", hostName: \"f1000research.com\", id: \"1\", editorialEmail: \"research@f1000.com\", infoEmail: \"info@f1000.com\", usePmcStats: true }); $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');}); // $(function(){R.ui.dropdowns('.dropdown-for-referees');}); $(document).ready(function () { if ($(\".cookie-warning\").is(\":visible\")) { $(\".sticky\").css(\"margin-bottom\", \"35px\"); $(\".devices\").addClass(\"devices-and-cookie-warning\"); } $(\".cookie-warning .close-button\").click(function (e) { $(\".devices\").removeClass(\"devices-and-cookie-warning\"); $(\".sticky\").css(\"margin-bottom\", \"0\"); }); $(\"#tweeter-feed .tweet-message\").each(function (i, message) { var self = $(message); self.html(linkify(self.html())); }); $(\".partner\").on(\"mouseenter mouseleave\", function() { $(this).find(\".gray-scale, .colour\").toggleClass(\"is-hidden\"); }); }); <!-- Sign in --> Sign In Remember me Forgotten your password? Sign In Cancel Email or password not correct. Please try again Please wait... $(function(){ // Note: All the setup needs to run against a name attribute and *not* the id due the clonish // nature of facebox... $(\"a[id=googleSignInButton]\").click(function(event){ event.preventDefault(); $(\"input[id=oAuthSystem]\").val(\"GOOGLE\"); $(\"form[id=oAuthForm]\").submit(); }); $(\"a[id=facebookSignInButton]\").click(function(event){ event.preventDefault(); $(\"input[id=oAuthSystem]\").val(\"FACEBOOK\"); $(\"form[id=oAuthForm]\").submit(); }); $(\"a[id=orcidSignInButton]\").click(function(event){ event.preventDefault(); $(\"input[id=oAuthSystem]\").val(\"ORCID\"); $(\"form[id=oAuthForm]\").submit(); }); }); If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password. The email address should be the one you originally registered with F1000. Email address not valid, please try again You registered with F1000 via Google, so we cannot reset your password. To sign in, please click here . If you still need help with your Google account password, please click here . You registered with F1000 via Facebook, so we cannot reset your password. To sign in, please click here . If you still need help with your Facebook account password, please click here . Code not correct, please try again Reset password Cancel Email us for further assistance. Server error, please try again. If your email address is registered with us, we will email you instructions to reset your password. If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance. Please wait... Register $(document).ready(function () { signIn.createSignInAsRow($(\"#sign-in-form-gfb-popup\")); $(\".target-field\").each(function () { var uris = $(this).val().split(\"/\"); if (uris.pop() === \"login\") { $(this).val(uris.toString().replace(\",\",\"/\")); } }); });","source_license":"CC-BY-4.0","license_restricted":false}